{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:29:14Z","timestamp":1782332954750,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd012586","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000}}],"reference-count":922,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012586.pub2","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T06:34:33Z","timestamp":1751351673000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis"],"prefix":"10.1002","volume":"2025","author":[{"given":"Pedro","family":"Melo","sequence":"additional","affiliation":[{"name":"Nuffield Department of Women's and Reproductive Health; University of Oxford; Oxford UK"},{"name":"Tommy's National Centre for Miscarriage Research, Institute of Metabolism and Systems Research; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abey","family":"Eapen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; University of Iowa Health Care; Iowa City Iowa USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yealin","family":"Chung","sequence":"additional","affiliation":[{"name":"Tommy's National Centre for Miscarriage Research, Institute of Metabolism and Systems Research; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadava","family":"Jeve","sequence":"additional","affiliation":[{"name":"Birmingham Women's and Children's NHS Foundation Trust; Birmingham UK"},{"name":"Department of Metabolism and Systems Science, College of Medicine and Health; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm J","family":"Price","sequence":"additional","affiliation":[{"name":"Department of Public Health; Canadian University Dubai; Dubai United Arab Emirates"},{"name":"School of Health and Population Sciences; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sesh Kamal","family":"Sunkara","sequence":"additional","affiliation":[{"name":"Division of Women's Health, Faculty of Life Sciences & Medicine; King's College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick S","family":"Macklon","sequence":"additional","affiliation":[{"name":"London Women's Clinic; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacoub","family":"Khalaf","sequence":"additional","affiliation":[{"name":"Assisted Conception Unit; Guy's and St Thomas' NHS Foundation Trust; London UK"},{"name":"The Assisted Conception Unit & Centre for PGT; Guy's and St Thomas' Hospital Foundation and King's College, London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Tobias","sequence":"additional","affiliation":[{"name":"Tommy\u2019s National Centre for Miscarriage Research, Institute of Metabolism and Systems Research (IMSR), WHO Collaborating Centre for Global Women\u2019s Health Research; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J","family":"Broekmans","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine and Gynecology; University Medical Center; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed K","family":"Khairy","sequence":"additional","affiliation":[{"name":"CARE Fertility; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis D","family":"Gallos","sequence":"additional","affiliation":[{"name":"Tommy\u2019s National Centre for Miscarriage Research, Institute of Metabolism and Systems Research (IMSR), WHO Collaborating Centre for Global Women\u2019s Health Research; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arri","family":"Coomarasamy","sequence":"additional","affiliation":[{"name":"Tommy\u2019s National Centre for Miscarriage Research, Institute of Metabolism and Systems Research (IMSR), WHO Collaborating Centre for Global Women\u2019s Health Research; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/09513590902770156","article-title":"Efficacy of recombinant versus human derived follicle stimulating hormone on the oocyte and embryo quality in IVF-ICSI cycles: randomised, controlled, multi-centre trial","volume":"25","author":"Abate","year":"2009","journal-title":"Gynecological Endocrinology"},{"issue":"Suppl","key":"10.1002\/14651858.CD012586.pub2-BIB0002|cit2","first-page":"i7","article-title":"Less miscarriage rate using LH (r-LH) in GNRH agonist long protocols","volume":"21","author":"Abdelmassih","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ajme.2012.04.001","article-title":"Effect of aromatase inhibitor (letrozole) with long agonist protocol on the results of ICSI\/ET in females with minimal and mild endometriosis","volume":"48","author":"Abd Rabbo","year":"2012","journal-title":"Alexandria Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.fertnstert.2010.01.051","article-title":"Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization\/intracytoplasmic sperm injection in patients with polycystic ovary syndrome","volume":"94","author":"Aboulghar","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.fertnstert.2004.03.020","article-title":"Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles","volume":"82","author":"Acevedo","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0015-0282(16)54964-4","article-title":"Prospective study of short and long regimens of gonadotropin-releasing hormone agonist in in vitro fertilisation program","volume":"57","author":"Acharya","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0015-0282(97)00559-1","article-title":"Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle-stimulating hormone","volume":"69","author":"Adonakis","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00404-012-2337-z","article-title":"Efficacy of low-dose hCG in late follicular phase in controlled ovarian stimulation using GnRH agonist protocol","volume":"286","author":"Aflatoonian","year":"2012","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0009|cit9","first-page":"430","article-title":"Low-dose human chorionic gonadotropin adjunct to an antagonist protocol in assisted reproductive technology: a randomized trial study","volume":"52","author":"Aghahosseini","year":"2014","journal-title":"Acta Medica Iranica"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/humrep\/15.10.2145","article-title":"Addition of GnRH antagonist in cycles of poor responders undergoing IVF","volume":"15","author":"Akman","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/humrep\/16.5.868","article-title":"Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial","volume":"16","author":"Akman","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group","volume":"15","author":"Albano","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0013|cit13","first-page":"1","article-title":"Comparing gonadotrophin-releasing hormone agonists or gonadotrophin- releasing hormone antagonists in poor responder in IVF","volume":"12","author":"Aletebi","year":"2007","journal-title":"Middle East Fertility Society Journal"},{"issue":"-","key":"10.1002\/14651858.CD012586.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"Corpus ID: 2147","DOI":"10.36295\/asro.2019.221015","article-title":"Comparison of sandwich, conventional antagonist and microdose protocols in poor responders","volume":"-","author":"Al-Jeborry","year":"2019","journal-title":"Annals of Tropical Medicine and Public Health"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0015|cit15","first-page":"i47 Abstract no","article-title":"Effectiveness of flexible GnRH antagonist protocol versus minidose long GnRH agonist protocol in poor-responder patients undergoing IVF","volume":"26","author":"Al-Karaki","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0016|cit16","first-page":"i298","article-title":"Is rLH useful in the treatment of infertile ipoor prognosisi patients undergoing IVF cycles? A preliminary report of a controlled, prospective, randomized trial","volume":"26 Suppl 1","author":"Allegra","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.rbmo.2017.05.001","article-title":"Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled study","volume":"35","author":"Alsbjerg","year":"2017","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0018|cit18","unstructured":"Study to examine effect of recombinant luteinizing hormone (r-LH) and recombinant human chorionic gonadotropin (r-HVG) for ovarian stimulation in assisted reproduction techniques (ART) https:\/\/clinicaltrials.gov\/show\/NCT01339299 2011"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0019|cit19","unstructured":"Alvino H Norman RJ Matthews CD Recombinant human follicle stimulation hormone (GONAL-F, SERONO) compared to urinary follicle stimulating hormone (metrodin) in IVF cycles: a randomised control study Fertility Society of Australia\/Australian Gynaecological Endoscopy Society; 1995 Nov 19-25; Melbourne, Australia Randwick, New South Wales Fertility Society of Australia 1995 46"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0020|cit20","first-page":"196","article-title":"Comparison between soft and conventional flexible antagonist protocols regarding ICSI outcome and pregnancy rate in women with poor ovarian reserve","volume":"23","author":"Alwan","year":"2023","journal-title":"HIV Nursing"},{"issue":"12","key":"10.1002\/14651858.CD012586.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/humrep\/del284","article-title":"Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial","volume":"21","author":"Andersen","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1472-6483(10)60380-X","article-title":"An economic evaluation of highly purified HMG and recombinant FSH based on a large randomized trial","volume":"15","author":"Wechowski","year":"2007","journal-title":"Reproductive Biomedicine Online"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.fertnstert.2008.01.034","article-title":"Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha","volume":"91","author":"Wechowski","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/humrep\/dem221","article-title":"Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF","volume":"22","author":"Ziebe","year":"2007","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/oxfordjournals.humrep.a137144","article-title":"Ovarian stimulation using human menopausal gonadotropins with\/without LHRH analogues in a long protocol for in-vitro fertilization: a prospective randomized comparison","volume":"5","author":"Antoine","year":"1990","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0028-2243(89)90063-4","article-title":"IVF-ET in women with refractory polycystic ovarian disease","volume":"30","author":"Ashkenazi","year":"1989","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0027|cit27","first-page":"593","article-title":"Evaluation of ovulation induction protocols for poor responders undergoing assisted reproduction techniques","volume":"26","author":"Ashrafi","year":"2005","journal-title":"Saudi Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0028|cit28","first-page":"14","article-title":"A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF\/ICSI cycles","volume":"3","author":"Ashrafi","year":"2005","journal-title":"Iranian Journal of Reproductive Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00404-010-1827-0","article-title":"The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety","volume":"284","author":"Ashrafi","year":"2011","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/09513590400019288","article-title":"Inclusion of standard and low-dose gonadotropin releasing hormone-analog (short protocol) in controlled ovarian hyperstimulation regimens in normogonadotropic patients aged 40-48 years who are undergoing in vitro fertilization","volume":"19","author":"Avrech","year":"2004","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0031|cit31","first-page":"ii248","article-title":"A randomised open-label trial comparing highly purified hMG and recombinant FSH in a GnRH agonist cycle","volume":"27 Suppl 2","author":"Aydin","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3109\/09513590.2014.929655","article-title":"Follicular fluid and serum vascular endothelial growth factor, interleukin (IL)-1beta and glycodelin concentrations: Comparison between long-gonadotropin-releasing hormone (GnRH)-Agonist and GnRH-Antagonist cycles: a randomized controlled trial","volume":"30","author":"Aydin","year":"2014","journal-title":"Gynecological Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/del484","article-title":"Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial","volume":"22","author":"Baart","year":"2007","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0034|cit34","first-page":"49","article-title":"Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis","volume":"10","author":"Badrawi","year":"2005","journal-title":"Middle East Society Fertility Journal"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0035|cit35","first-page":"84","article-title":"Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study","volume":"50","author":"Bahceci","year":"2005","journal-title":"Journal of Reproductive Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.fertnstert.2008.01.064","article-title":"Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial","volume":"91","author":"Baker","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1093\/oxfordjournals.humrep.a019123","article-title":"Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization","volume":"11","author":"Balasch","year":"1996","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1023\/A:1016662100572","article-title":"The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction","volume":"18","author":"Balasch","year":"2001","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1472-6483(10)61726-9","article-title":"Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction","volume":"7","author":"Balasch","year":"2003","journal-title":"Reproductive Biomedicine Online"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2004.06.076","article-title":"A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist\/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist\/rFSH in women pretreated with oral contraceptives before in vitro fertilization","volume":"83","author":"Barmat","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.fertnstert.2007.03.088","article-title":"Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles","volume":"89","author":"Barrenetxea","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF01555440","article-title":"GnRH analogs in ovulation induction for in vitro fertilization: benefit of a short administration regimen","volume":"4","author":"Barriere","year":"1987","journal-title":"Journal of In Vitro Fertilisation & Embryo Transfer"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/humrep\/14.Suppl_3.256","article-title":"A prospective and randomized study of ovarian stimulation for ICSI with recombinant FSH versus highly purified urinary FSH","volume":"14","author":"Baruffi","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0044|cit44","first-page":"1","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"16","author":"Basly","year":"2012","journal-title":"Internet Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2016.05.027","article-title":"A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response","volume":"203","author":"Bastu","year":"2016","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/09513590009167698","article-title":"The use of a starting dose of recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study","volume":"14","author":"Battaglia","year":"2000","journal-title":"Gynecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.4081\/ejtm.2022.10634","article-title":"Comparison of two ovarian stimulation protocols among women with poor response: a randomized clinical trial","volume":"32","author":"Bavarsadkarimi","year":"2022","journal-title":"European Journal of Translational Myology"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/humrep\/dez034","article-title":"Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial","volume":"34","author":"Begueria","year":"2019","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0015-0282(16)60315-1","article-title":"An increased initial follicle-stimulating hormone\/luteinizing hormone ratio does not affect ovarian responses and the outcomes of in vitro fertilization","volume":"50","author":"Benadiva","year":"1988","journal-title":"Fertility and Sterility"},{"issue":"91","key":"10.1002\/14651858.CD012586.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-7-91","article-title":"'hCG priming' effect in controlled ovarian stimulation through a long protocol","volume":"7","author":"Beretsos","year":"2009","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/humrep\/14.Suppl_3.61-a","article-title":"An open, randomized, group-comparative bi-centre study comparing recombinant FSH Follitropinum B 150 IU and highly purified urinary FSH 225 IU as a fixed dose regimen in IVF\/ICSI treatment","volume":"14","author":"Berger","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/humrep\/12.10.2133","article-title":"Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques","volume":"12","author":"Bergh","year":"1997","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.fertnstert.2006.11.150","article-title":"Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders","volume":"88","author":"Berkkanoglu","year":"2007","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0054|cit54","first-page":"i445","article-title":"Prospective randomized study comparing two short IVF protocols for low ovarian reserve","volume":"32","author":"Blasco","year":"2017","journal-title":"Human Reproduction. Conference: 33rd Annual Meeting of the European Society of Human Reproduction and Embryology. Switzerland"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1093\/humrep\/del152","article-title":"Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial","volume":"21","author":"Bodri","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0056|cit56","first-page":"1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial The European Orgalutran Study Group [published erratum appears in Hum Reprod 2000 Aug;15(8):1877]","volume":"15","author":"Borm","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/humrep\/den220","article-title":"Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists--a randomized study","volume":"23","author":"Bosch","year":"2008","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.fertnstert.2010.10.021","article-title":"Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis","volume":"95","author":"Bosch","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/humrep\/dead251","article-title":"Serum progesterone is lower in ovarian stimulation with highly purified HMG compared to recombinant FSH owing to a different regulation of follicular steroidogenesis: a randomized controlled trial","volume":"39","author":"Bosch","year":"2024","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7827-8-25","article-title":"Differential gene expression in human granulosa cells from recombinant FSH versus human menopausal gonadotropin ovarian stimulation protocols","volume":"8","author":"Brannian","year":"2010","journal-title":"Reproductive Biology and Endocrinology: RB&E"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humrep\/deab249","article-title":"Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial","volume":"37","author":"B\u00fclow","year":"2022","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0062|cit62","first-page":"132","article-title":"Comparison of microdose GnRH agonist protocol with GnRH antagonist\/letrazole protocol in patients with poor ovarian response","volume":"10","author":"Cakiroglu Y Kopuk SY Basarir O Filiz S Vural","year":"2013","journal-title":"Turk Jinekoloji ve Obstetrik Dernegi Dergisi"},{"issue":"12","key":"10.1002\/14651858.CD012586.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s10815-012-9863-2","article-title":"MILD ovarian stimulation with GnRH-antagonist vs. long protocol with low dose FSH for non-PCO high responders undergoing IVF: a prospective, randomized study including thawing cycles","volume":"29","author":"Casano","year":"2012","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3109\/09513590.2010.544133","article-title":"Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF\/ET and reduces cancellation rate for high risk of hyperstimulation?","volume":"27","author":"Caserta","year":"2011","journal-title":"Gynecological Endocrinology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0065|cit65","first-page":"212","article-title":"Efficacy and safety of gonadotrophin releasing hormone (GnRH) antagonist administration in infertile women during controlled ovarian hyperstimulation (abstract)","volume":"14","author":"Cattani","year":"2000","journal-title":"Gynecological Endocrinology"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/humrep\/deh369","article-title":"Recombinant human LH supplementation during GnRH antagonist administration in IVF\/ICSI cycles: a prospective randomized study","volume":"19","author":"Cedrin-Durnerin","year":"2004","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0067|cit67","doi-asserted-by":"crossref","unstructured":"Low dose of gonadotropin with letrozole versus high dose of gonadotropin in patients with poor ovarian response undergoing ivf: a randomised, single-blind, prospective trial Zeynep Kamil T\u0131p B\u00fclteni 51 4 221 5 10.16948\/zktipb.775168","DOI":"10.16948\/zktipb.775168"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"D40","DOI":"10.1016\/S0020-7292(00)81782-8","article-title":"Randomized comparative study of recombinant versus highly purified urinary follicle stimulating hormone in controlled ovarian stimulation: our experience","volume":"70","author":"Chakravarty","year":"2000","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0069|cit69","first-page":"131","article-title":"Randomized controlled trial comparing embryonic quality in rFSH versus hMG in the IVF protocol with GnRH antagonist","volume":"25","author":"Chapon RC","year":"2021","journal-title":"JBRA Assisted Reproduction"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.gyobfe.2011.08.025","article-title":"Prospective randomised study of long versus short agonist protocol with poor responder patients during in vitro fertilization","volume":"40","author":"Chatillon-Boissier","year":"2012","journal-title":"Gynecologie Obstetrique Fertilite & Senologie"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0071|cit71","first-page":"257","article-title":"Effect of antagonists vs agonists on in vitro fertilization outcome","volume":"31","author":"Check","year":"2004","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0072|cit72","first-page":"217","article-title":"A prospective comparison of in vitro fertilization (IVF) outcome following controlled ovarian hyperstimulation (COH) regimens using follitropin alpha exclusively or with the addition of low dose human chorionic gonadotropin (hCG) and ganirelix","volume":"36","author":"Check","year":"2009","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1016\/j.fertnstert.2004.07.603","article-title":"An open, prospective, randomized, multicenter study to compare recombinant human follicle stimulating hormone (rec-FSH; follitropin-; Puregon\u00ae solution) with highly purified urinary FSH (uFSH, urofollitropin (highly purified), Metrodin\u00ae HP) in Chinese women undergoing in vitro fertilization (IVF)","volume":"82","author":"Chen","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0074|cit74","first-page":"733","article-title":"Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques","volume":"49","author":"Cheon","year":"2004","journal-title":"Journal of Reproductive Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/humrep\/deh668","article-title":"GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial","volume":"20","author":"Cheung","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1477-7827-10-33","article-title":"GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology","volume":"10","author":"Cota","year":"2012","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.rbmo.2017.03.003","article-title":"Economic impact of ovarian stimulation with corifollitropin alfa versus conventional daily gonadotropins in oocyte donors: a randomized study","volume":"34","author":"Cruz","year":"2017","journal-title":"Reproductive Biomedicine Online"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1028-4559(10)60064-2","article-title":"GnRH antagonist\/letrozole versus microdose GnRH agonist flare protocol in poor responders undergoing in vitro fertilization","volume":"49","author":"Davar","year":"2010","journal-title":"Taiwanese Journal of Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00404-012-2522-0","article-title":"A comparative study of luteal estradiol pre-treatment in GnRH antagonist protocols and in micro dose flare protocols for poor-responding patients","volume":"287","author":"Davar","year":"2013","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0080|cit80","first-page":"255","article-title":"Pregnancy outcome in delayed start antagonist versus microdose flare GnRH agonist protocol in poor responders undergoing IVF\/ICSI: an RCT","volume":"16","author":"Davar","year":"2018","journal-title":"International Journal of Reproductive BioMedicine"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/HUMREP\/10.6.1392","article-title":"Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in-vitro fertilization","volume":"10","author":"Daya","year":"1995","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.rbmo.2019.10.008","article-title":"Replacing HMG\/FSH by low-dose HCG to complete corifollitropin alfa stimulation reduces cost per clinical pregnancy: a randomized pragmatic trial","volume":"40","author":"Decleer","year":"2020","journal-title":"Reproductive Biomedicine Online"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0083|cit83","first-page":"i72","article-title":"Supplementation of rec LH for poor responder patients in ART","volume":"20","author":"Demirol","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.fertnstert.2008.07.006","article-title":"Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study","volume":"92","author":"Demirol","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/09513590802617762","article-title":"Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols for invitro fertilisation and embryo transfer","volume":"25","author":"Depalo","year":"2009","journal-title":"Gynecological Endocrinology"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/humrep\/16.9.1875","article-title":"Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH","volume":"16","author":"De Placido","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/humrep\/deh625","article-title":"Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial","volume":"20","author":"De Placido","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.fertnstert.2005.07.1280","article-title":"Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response","volume":"85","author":"De Placido","year":"2006","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0089|cit89","unstructured":"De Sutter P Schats R Bassil S Kremer JAM Tournaye H A randomised prospective, assessor-blind, multicentre study to compare the efficacy and safety of Gonal-F\u00ae with that of Metrodin\u00ae HP for the induction of superovulation in women undergoing ART 1st Congress on Controversies in Obstetrics, Gynecology & Infertility, Prague, 28-31 October, 1999 1999 8"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/09513591003632191","article-title":"Poor prognosis for ovarian response to stimulation: results of a randomised trial comparing the flare-up GnRH agonist protocol vs. the antagonist protocol","volume":"26","author":"Devesa","year":"2010","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/oxfordjournals.humrep.a135938","article-title":"A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilization","volume":"10","author":"Devroey","year":"1995","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.fertnstert.2011.12.016","article-title":"A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer","volume":"97","author":"Devroey","year":"2012","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0093|cit93","first-page":"ii302","article-title":"Cumulative live birth rates after compulsory single blastocyst transfer in fresh and frozen cycles: follow up data from a RCT comparing HP- hMG and rFSH","volume":"27 Suppl 2","author":"Devroey","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"S176 P","DOI":"10.1016\/j.fertnstert.2011.07.686","article-title":"Live birth rate after single blastocyst transfer in a GnRH antagonist cycle using highly purified menotropin or recombinant FSH for controlled ovarian stimulation","volume":"96 Suppl","author":"Nyboe Andersen","year":"2011","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0095|cit95","first-page":"i118 Abstract n","article-title":"A randomised trial (MEGASET) comparing highly purified menotropin and recombinant FSH in a GnRH antagonist cycle with single blastocyst transfer","volume":"26 Suppl 1","author":"Nyboe Andersen","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0015-0282(01)02225-7","article-title":"A new highly purified human-derived FSH is efficacious and well-tolerated in a prospective, randomized comparative clinical trial of in-vitro fertilization","volume":"76","author":"Dickey","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012586.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"S183, Abstract","DOI":"10.1016\/S0015-0282(03)01387-6","article-title":"Oral contraceptive pretreatment for scheduling in IVF patients treated with either rFSH\/GnRH Antagonist or rFSH\/GnRH agonist","volume":"80","author":"Dickey","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1477-7827-1-63","article-title":"Highly purified human-derived follicle-stimulating hormone (Bravelle) has equivalent efficacy to follitropin-beta (Follistim) in infertile women undergoing in vitro fertilization","volume":"1","author":"Dickey","year":"2003","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.fertnstert.2011.01.134","article-title":"A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders","volume":"95","author":"DiLuigi","year":"2011","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01133025","article-title":"A randomised prospective study on the effect of short and long buserelin treatment in women with repeated unsuccessful in vitro fertilisation (IVF) cycles due to inadequate ovarian response","volume":"8","author":"Dirnfeld","year":"1991","journal-title":"Journal of in Vitro Fertilization and Embryo Transfer"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0101|cit101","first-page":"286","article-title":"A comparative study of the effect of ovarian stimulation protocols with different gonadotropin preparations on the biological and clinical parameters of the outcome of intracytoplasmic sperm injection","volume":"29","author":"Drakakis","year":"2002","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0102|cit102","first-page":"64","article-title":"The clinical efficacy of recombinant FSH (r-FSH) as compared to highly purified urinary gonadotrophin (hMG-FD) and the use of a low starting dose of r-FSH in IVF or ICSI. A randomized prospective study","volume":"14","author":"Drakakis","year":"2002","journal-title":"Italian Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejogrb.2004.12.021","article-title":"Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET","volume":"121","author":"Drakakis","year":"2005","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1477-7827-7-110","article-title":"Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation","volume":"7","author":"Drakakis","year":"2009","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/humrep\/dex296","article-title":"Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial","volume":"32","author":"Drakopoulos","year":"2017","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"e002938","DOI":"10.1136\/bmjopen-2013-002938","article-title":"Corifollitropin alpha followed by menotropin for poor ovarian responders' trial (COMPORT): a protocol of a multicentre randomised trial","volume":"3","author":"Polyzos","year":"2013","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0107|cit107","first-page":"i71 Abstract no","article-title":"Supplementation of recombinant LH to poor responders in mid-follicular phase along with recombinant FSH results in better blastocyst formation and implantation rate in antagonist IVF cycles","volume":"30 Suppl 1","author":"Dravid","year":"2015","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0108|cit108","first-page":"306","article-title":"Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH\/LH ratios. I Comparison of an FSH-dominant and a purified FSH preparation","volume":"42","author":"Duijkers","year":"1997","journal-title":"International Journal of Fertility and Women's Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/humrep\/dem388","article-title":"Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation","volume":"23","author":"Durnerin","year":"2008","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0110|cit110","first-page":"101","article-title":"Letrozole+ GnRH antagonist stimulation protocol in poor ovarian responders undergoing intracytoplasmic sperm injection cycles: an RCT","volume":"15","author":"Ebrahimi","year":"2017","journal-title":"International Journal of Reproductive Biomedicine"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"483","DOI":"10.18502\/ijrm.v20i6.11444","article-title":"Co-treatment of gonadotropin and letrozole in infertile women with endometriosis: a double-blind randomized clinical trial","volume":"20","author":"Ebrahimi","year":"2022","journal-title":"International Journal of Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0015-0282(16)53224-5","article-title":"Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gondadotropin-releasing hormone agonist suppression","volume":"53","author":"Edelstein","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0113|cit113","first-page":"187","article-title":"Ovarian stimulation using a recombinant FSH preparation and an LHRH antagonist (cetrorelix) or agonist (Buserelin)","volume":"2","author":"Edi-Osagie","year":"1999","journal-title":"Human Fertility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0114|cit114","first-page":"65","article-title":"Letrozole-human menopausal gonadotrophin for intracytoplasmic sperm injection in polycystic ovarian syndrome","volume":"124","author":"El Kassar","year":"2017","journal-title":"BJOG"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD012586.pub2-BIB0115|cit115","first-page":"27","article-title":"GnRH agonists versus GnRH antagonists in controlled ovarian stimulation in ICSI cycles","volume":"86","author":"El-Sahwi","year":"2006","journal-title":"XVIII FIGO World Congress of Gynecology and Obstetrics Kuala Lumpur Malaysia 5-10 November 2006"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S1472-6483(10)62165-7","article-title":"Single dose application of cetrorelix in combination with clomiphene for friendly IVF: results of a feasibility study","volume":"6","author":"Engel","year":"2003","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0117|cit117","unstructured":"Lutropin alfa (Luveris) in mid follicular phase for controlled ovarian stimulation (COS) in ovarian ageing: a randomised, comparative with parallel control group, phase II clinical trial. Lutropin alfa in mid follicular phase http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2004-001503-36-ES"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0118|cit118","unstructured":"A prospective, open label, randomised, parallel group trial comparing the effects of highly purified menotrophin and recombinant follicle stimulating hormone (rfsh, follitropin alpha) administered subcutaneoulsy to subfertile female patients undergoing IVF using antagonist down-regulation on progesterone serum levels during the follicular phase and their possible use as predictors for the success rate of ongoing pregnancies (PREDICT) - PREDICT https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2010-019411-37-DE"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.fertnstert.2005.09.049","article-title":"Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age","volume":"85","author":"Fabregues","year":"2006","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0120|cit120","first-page":"i331 Abstract n","article-title":"Evaluation of recombinant human luteinizing hormone supplementation in down-regulated women of advanced reproductive age undergoing follicular stimulation for IVF","volume":"26 Suppl 1","author":"Fabregues","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"15","key":"10.1002\/14651858.CD012586.pub2-BIB0121|cit121","first-page":"719","article-title":"Luteinizing hormone inhibition with an LH-RH analogue, triptorelin, in ovarian stimulation for in vitro fertilization. Choice of the therapeutic regimen","volume":"17","author":"Fenichel","year":"1988","journal-title":"Presse Medicale (Paris, France: 1983)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0122|cit122","first-page":"231","article-title":"Highly purified urinary FSH is not completely analagous to previous gonadotrophin preparations in assisted reproduction techniques","volume":"11","author":"Ferrareti","year":"1996","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.fertnstert.2004.06.041","article-title":"Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques","volume":"82","author":"Ferraretti","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejogrb.2005.08.017","article-title":"Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist\/FSH ovarian stimulation cycles","volume":"124","author":"Ferrari","year":"2006","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00404-009-1073-5","article-title":"Comparing GnRH agonist long protocol and GnRH antagonist protocol in outcome the first cycle of ART","volume":"281","author":"Firouzabadi","year":"2010","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF02214125","article-title":"Superovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol): a comparative study","volume":"12","author":"Fisch","year":"1995","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/oxfordjournals.humrep.a019506","article-title":"Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity","volume":"11","author":"Fleming","year":"1996","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(00)01638-1","article-title":"Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation","volume":"75","author":"Fluker","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.fertnstert.2006.05.078","article-title":"Effects of gonadotropin-releasing hormone agonist\/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist\/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization","volume":"87","author":"Fornaro","year":"2007","journal-title":"Fertility and Sterility"},{"issue":"7-8","key":"10.1002\/14651858.CD012586.pub2-BIB0130|cit130","first-page":"628","article-title":"Randomized study of short and long buserelin regimen in 100 IVF cycles","volume":"16","author":"Foulot","year":"1988","journal-title":"Contraception, Fertilite, Sexualite"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/09513590009167653","article-title":"A prospective and randomized study of ovarian stimulation for ICSI with recombinant FSH versus highly purified urinary FSH","volume":"14","author":"Franco","year":"2000","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0132|cit132","first-page":"26","article-title":"Comparison of ovarian stimulation with recombinant FSH after 2 nd phase protocols with GnRH analogs (I - estradiol + ganirelix versus II - nafarelin). [Portuguese]","volume":"7","author":"Franco Jr","year":"2003","journal-title":"Jornal Brasileiro de Reproducao Assistida"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1016\/j.fertnstert.2004.07.613","article-title":"Gonadotropin-releasing hormone (GnRH)-agonist versus GnRH-antagonist in ovarian stimulation for assisted reproductive techniques: Results of a prospective randomized trial","volume":"82","author":"Freitas","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1472-6483(10)60976-5","article-title":"Luteal phase characteristics following GnRH antagonist or agonist treatment - a comparative study","volume":"12","author":"Friedler","year":"2006","journal-title":"Reproductive Biomedicine Online"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0015-0282(16)60135-8","article-title":"Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program","volume":"50","author":"Frydman","year":"1988","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/humrep\/15.3.520","article-title":"A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection","volume":"15","author":"Frydman","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.fertnstert.2014.07.224","article-title":"Efficacy of clomiphene citrate supplementation to conventional GnRH antagonist protocols in poor responders undergoing assisted reproductive technology-a prospective randomized trial","volume":"102 Suppl","author":"Fujimoto","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-020-00628-6","article-title":"Corifollitropin alfa for poor responders patients, a prospective randomized study","volume":"18","author":"Fusi","year":"2020","journal-title":"Reproductive Biology and Endocrinology: RB&E"},{"issue":"Suppl","key":"10.1002\/14651858.CD012586.pub2-BIB0139|cit139","first-page":"i2","article-title":"Agonist vs antagonist use in PCO patients in IVF programme: hormone profiles and outcome","volume":"21","author":"Galera","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0140|cit140","first-page":"43","article-title":"The treatment with recombinant FSH improvement the embryo quality in IVF cycles: a prospective randomiced study. [Spanish]","volume":"20","author":"Gallego Pastor","year":"2003","journal-title":"Revista Iberoamericana de Fertilidad y Reproduccion Humana"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.fertnstert.2011.06.022","article-title":"Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial","volume":"96","author":"Garcia-Velasco","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.fertnstert.2005.07.313","article-title":"Impact of GnRH agonist versus GnRH antagonist during controlled ovarian hyperstimulation (COH) on oocyte maturity and aneuploidy: a pilot study","volume":"84","author":"Ghadir","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.fertnstert.2005.01.031","article-title":"GnRH agonist versus GnRH antagonist during controlled ovarian hyperstimulation (COH): is there an effect on oocyte maturity and aneuploidy?","volume":"83","author":"Ghadir","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0144|cit144","first-page":"1","article-title":"Pregnancy outcomes in PCOS patients undergoing IVF with long GnRH agonist protocol versus flexible GnRH antagonist","volume":"21","author":"Ghaebi","year":"2018","journal-title":"Iranian Journal of Obstetrics, Gynecology and Infertility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0145|cit145","first-page":"41","article-title":"Effect of oral Utrogestan in comparison with Cetrotide on preventing luteinizing hormone surge in IVF cycles: a randomized controlled trial","volume":"18","author":"Ghasemzadeh","year":"2019","journal-title":"International Journal of Reproductive Biomedicine (Yazd, Iran)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0146|cit146","first-page":"97","article-title":"Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study","volume":"14","author":"Gholami","year":"2010","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1016\/j.fertnstert.2020.08.1322","article-title":"Prognostic factors of ovarian response after follicular protocol with MPA trigger with GnRH agonist","volume":"114","author":"Giles","year":"2020","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0148|cit148","doi-asserted-by":"crossref","unstructured":"Alama P Gamiz P Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial Fertility and Sterility 2021 116 2 404 12","DOI":"10.1016\/j.fertnstert.2021.02.036"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0149|cit149","first-page":"136","article-title":"Embryo morphology and ovarian stimulation protocol: a prospective study for ICSI with recombinant FSH versus highly purified urinary FSH","volume":"2","author":"Gonzalez-Gomez","year":"2000","journal-title":"XVI FIGO World Congress of O & G Washington DC Sept 3-8 2000"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(00)01701-5","article-title":"A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome","volume":"75","author":"Gordon","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0151|cit151","first-page":"82","article-title":"A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF","volume":"4","author":"Gordts","year":"2012","journal-title":"Facts Views & Vision in Obgyn"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/humrep\/deh359","article-title":"A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report","volume":"19","author":"Goswami","year":"2004","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/deh741","article-title":"Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol","volume":"20","author":"Griesinger","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.fertnstert.2008.02.137","article-title":"Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin","volume":"91","author":"Gr\u00f8ndahl","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0015-0282(16)56947-7","article-title":"Should gonadotropin-releasing hormone down-regulation therapy be routine in in vitro fertilization?","volume":"62","author":"Harrison","year":"1994","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00404-012-2348-9","article-title":"IVF\/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial","volume":"286","author":"Haydardedeoglu","year":"2012","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0015-0282(16)55806-3","article-title":"Comparison of short 7-day and prolonged treatment with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation","volume":"59","author":"Hazout","year":"1993","journal-title":"Fertility and Sterility"},{"issue":"7-8","key":"10.1002\/14651858.CD012586.pub2-BIB0158|cit158","first-page":"624","article-title":"Randomized study of short and long regimen of GnRH agonists in an IVF programme","volume":"16","author":"Hedon","year":"1988","journal-title":"Contraception, Fertilite, Sexualite"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1093\/oxfordjournals.humrep.a135866","article-title":"Efficacy and safety of recombinant follicle stimulating hormone (FSH\/Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective- randomized- assessor-blind- multicentre trial","volume":"10","author":"Hedon","year":"1995","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejogrb.2014.12.021","article-title":"GnRH-antagonist programming versus GnRH agonist protocol: a randomized trial","volume":"185","author":"Hershko Klement","year":"2015","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1472-6483(10)60476-2","article-title":"Prospective comparison of short and long GnRH agonist protocols using recombinant gonadotrophins for IVF\/ICSI treatments","volume":"16","author":"Ho","year":"2008","journal-title":"Reproductive Biomedicine Online"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0162|cit162","first-page":"72","article-title":"Mild ovarian stimulation for IVF: a randomized trial","volume":"17","author":"Hohmann","year":"2002","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1210\/jc.2002-020788","article-title":"A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol","volume":"88","author":"Hohmann","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"e3633","DOI":"10.1210\/clinem\/dgac409","article-title":"The impact of suppressing estradiol during ovarian stimulation on the unsupported luteal phase: a randomized controlled trial","volume":"107","author":"Dreyer Holt","year":"2022","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.humrep.a137035","article-title":"Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries","volume":"5","author":"Homburg","year":"1990","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.fertnstert.2007.05.039","article-title":"Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients","volume":"89","author":"Hompes","year":"2008","journal-title":"Fertility and Sterility"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/humrep\/14.10.2442","article-title":"A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon((R))) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP((R))) in a fixed-dose regimen in women undergoing ovarian stimulation","volume":"14","author":"Hoomans","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40199-014-0067-4","article-title":"A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression","volume":"22","author":"Hoseini","year":"2014","journal-title":"Daru"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0169|cit169","first-page":"14","article-title":"Comparison of dydrogesterone and GnRH antagonists for prevention of premature LH surge in IVF\/ICSI cycles: a randomized controlled trial","volume":"14","author":"Hossein","year":"2020","journal-title":"Journal of Family and Reproductive Health"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1447-0756.2010.01247.x","article-title":"Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients","volume":"36","author":"Hosseini","year":"2010","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15296\/ijwhr.2022.34","article-title":"The comparison the impact of flare-up GnRH agonist with delayed-start GnRH antagonist protocols on the IVF outcome of poor responder patients: a randomized controlled trial","volume":"10","author":"Hosseinishenatal","year":"2022","journal-title":"International Journal of Women's Health and Reproduction Sciences"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1028-4559(08)60057-1","article-title":"Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization","volume":"47","author":"Hsieh","year":"2008","journal-title":"Taiwanese Journal of Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1009408029509","article-title":"Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization-embryo transfer","volume":"18","author":"Hugues","year":"2001","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/humrep\/del030","article-title":"Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF\/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study","volume":"21","author":"Huirne","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1472-6483(10)61643-4","article-title":"Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: An opening study","volume":"8","author":"Humaidan","year":"2004","journal-title":"Reproductive Biomedicine Online"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0176|cit176","first-page":"544","article-title":"Efficacy and safety of follitropin alfa\/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders","volume":"32","author":"Humaidan","year":"2017","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh375","article-title":"Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study","volume":"19","author":"Hwang","year":"2004","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.mefs.2011.06.003","article-title":"Micro-dose flare-up gonadotrophin-releasing hormone (GnRH) agonist vs. flexible gonadotrophin-releasing hormone (GnRH) antagonist protocol in patient with poor ovarian reserve","volume":"16","author":"Ibrahim","year":"2011","journal-title":"Middle East Fertility Society Journal"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0179|cit179","first-page":"22","article-title":"The impact of HMG on follicular fluid hormone levels, embryo quality and IVF outcome","volume":"19","author":"Ilhana","year":"2014","journal-title":"Eastern Journal of Medicine"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0180|cit180","first-page":"95","article-title":"A randomized comparative study of Metrodin with or without pituitary down-regulation in COH for IVF-embryo transfer","volume":"13","author":"Imoedemhe","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0181|cit181","unstructured":"Impact of letrozol on improvement oocyte quality and IVF outcome in infertile patients underwent controlled ovarian stimulation https:\/\/en.irct.ir\/trial\/46787 2020"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/humrep\/13.11.2995","article-title":"A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients","volume":"13","author":"Jansen","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0183|cit183","first-page":"206","article-title":"A prospective randomized comparative cohort study of either recombinant FSH (Puregon) or urinary FSH (Metrodin) in in vitro fertilization treatment","volume":"4","author":"Kahn","year":"1999","journal-title":"Middle East Fertility Society Journal"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0184|cit184","first-page":"i122","article-title":"A comparison of aromatase inhibitor plus recombinant-FSH \/ GnRH antagonist versus recombinant-FSH microdose co-flare analog protocols in poor responders undergone ICSI\/ET","volume":"20","author":"Kahraman","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.fertnstert.2008.03.057","article-title":"Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle","volume":"91","author":"Kahraman","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00404-009-1252-4","article-title":"Comparison of mild stimulation and conventional stimulation in ART outcome","volume":"281","author":"Karimzadeh","year":"2010","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rbmo.2010.03.017","article-title":"GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation pathway of aromatase expression in human granulosa cells","volume":"21","author":"Khalaf","year":"2010","journal-title":"Reproductive Biomedicine Online"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/humrep\/deg252","article-title":"A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: Ovarian response and clinical outcomes","volume":"18","author":"Kilani","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0189|cit189","doi-asserted-by":"crossref","unstructured":"GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF\/ICSI Clinical and Experimental Reproductive Medicine 2011 38 4 228 33","DOI":"10.5653\/cerm.2011.38.4.228"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5653\/cerm.2012.39.1.22","article-title":"Effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystic ovary syndrome undergoing IVF\/ICSI","volume":"39","author":"Kim","year":"2012","journal-title":"Clinical and Experimental Reproductive Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0015-0282(16)54962-0","article-title":"The routine use of gonadotropin-releasing hormone agonists for all patients undergoing in vitro fertilization Is there any medical advantage? A prospective randomized study","volume":"57","author":"Kingsland","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10815-006-9036-2","article-title":"Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol","volume":"23","author":"Koichi","year":"2006","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/humrep\/det266","article-title":"Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF\/ICSI: a randomized controlled multicentre study","volume":"28","author":"Konig","year":"2013","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0194|cit194","first-page":"i314","article-title":"The influence of LH substitution for GnRH antagonist blocked endogenous LH in older IVF patients","volume":"26 Suppl 1","author":"Van Der Houwen","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.fertnstert.2008.12.010","article-title":"Results with early follicular phase recombinant luteinizing hormone supplementation during stimulation for in vitro fertilization","volume":"93","author":"Kovacs","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0301-2115(02)00476-1","article-title":"A pilot study of the use of low dose human menopausal gonadotropin in ovulation induction","volume":"109","author":"Ku","year":"2003","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10815-008-9249-7","article-title":"Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study","volume":"25","author":"Kurzawa","year":"2008","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.fertnstert.2004.07.084","article-title":"A prospective randomized study of three ovulation induction protocols for IVF: GnRH agonist versus antagonist with and without low dose hCG","volume":"82","author":"Kyono","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejogrb.2017.01.011","article-title":"Recombinant LH supplementation in patients with a relative reduction in LH levels during IVF\/ICSI cycles: a prospective randomized controlled trial","volume":"210","author":"Lahoud","year":"2017","journal-title":"European Journal of Obstetics, Gynecology and Reproductive Biology"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/humrep\/dem033","article-title":"Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development","volume":"22","author":"Lainas","year":"2007","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/humrep\/den107","article-title":"Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial","volume":"23","author":"Lainas","year":"2008","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2012.07.014","article-title":"GnRH agonist versus GnRH antagonist in IVF\/ICSI cycles with recombinant LH supplementation: DNA fragmentation and apoptosis in granulosa cells","volume":"165","author":"Lavorato","year":"2012","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0015-0282(16)60011-0","article-title":"Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study","volume":"50","author":"Lavy","year":"1988","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.rbmo.2011.05.012","article-title":"Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial","volume":"23","author":"Lee","year":"2011","journal-title":"Reproductive Biomedicine Online"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/humrep\/15.5.1021","article-title":"Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP)","volume":"15","author":"Lenton","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0207|cit207","first-page":"i420 Abstract n","article-title":"Recombinant FSH plus highly purified hMG versus recombinant FSH on ovarian response and clinical outcomes in long GnRH agonist protocol: a prospective, randomized, controlled trial","volume":"31 Supp1","author":"Li","year":"2016","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/09513590600702733","article-title":"Comparison of outcome of clomiphene citrate\/human menopausal gonadotropin\/cetrorelix protocol and buserelin long protocol--a randomized study","volume":"22","author":"Lin","year":"2006","journal-title":"Gynecological Endocrinology"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3109\/09513590.2011.652716","article-title":"Recombinant luteinizing hormone priming in multiple follicular stimulation for in-vitro fertilization in downregulated patients","volume":"28","author":"Lisi","year":"2012","journal-title":"Gynecological Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0210|cit210","first-page":"385","article-title":"Efficacy of highly purified urinary FSH versus recombinant FSH in Chinese women over 37 years undergoing assisted reproductive techniques","volume":"8","author":"Liu","year":"2015","journal-title":"International Journal of Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/cen.13532","article-title":"Progestin-primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing in vitro fertilization\/intracytoplasmic sperm injection: A prospective randomized controlled trial","volume":"88","author":"Liu","year":"2018","journal-title":"Clinical Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00404-020-05513-6","article-title":"Mild stimulation protocol vs conventional controlled ovarian stimulation protocol in poor ovarian response patients: a prospective randomized controlled trial","volume":"301","author":"Liu","year":"2020","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0213|cit213","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/humrep\/deae092","article-title":"BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle","volume":"39","author":"Lobo","year":"2024","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0214|cit214","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.47750\/pnr.2022.13.S07.569","article-title":"Gonadotropins- letrozole, gonadotropin- clomiphene citrate, and gonadotropins only for controlled ovarian super stimulation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection","volume":"30","author":"Lotfy","year":"2022","journal-title":"Journal of Pharmaceutical Negative Results"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0015-0282(16)57795-4","article-title":"Luteal phase consequences of low-dose gonadotropin-releasing hormone agonist therapy in nonluteal-supported in vitro fertilization cycles","volume":"64","author":"Long","year":"1995","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0015-0282(16)60437-5","article-title":"Hormonal changes induced by short-term administration of gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development","volume":"51","author":"Loumaye","year":"1989","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0217|cit217","first-page":"S432","article-title":"A prospective randomised study to evaluate the clinical efficacy of recFSH as compared to hMG-FD in IVF-ET","volume":"70","author":"Loutradis","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.fertnstert.2004.04.051","article-title":"A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol","volume":"82","author":"Loutradis","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0219|cit219","unstructured":"Comparison of short agonist vs long agonist stimulation protocol and different pretreatment s in women undergoing in vitro fertlization http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT2015020418202N4 2015"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"Article number:","DOI":"10.1155\/2015\/628056","article-title":"Estradiol valerate pretreatment in short protocol GnRH-agonist cycles versus combined pretreatment with oral contraceptive pills in long protocol GnRH-agonist cycles: A randomised controlled trial","volume":"2015","author":"Lukaszuk","year":"2015","journal-title":"BioMed Research International"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10815-012-9854-3","article-title":"Efficacy of low dose hCG on oocyte maturity for ovarian stimulation in poor responder women undergoing intracytoplasmic sperm injection cycle: a randomized controlled trial","volume":"29","author":"Madani","year":"2012","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0222|cit222","first-page":"i314","article-title":"A comparative study to examine the relative efficiency of hMG versus recombinant LH for LH activity supplementation in recombinant FSH cycles in art","volume":"25 Suppl 1","author":"Maity","year":"2010","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.rbmo.2016.11.014","article-title":"Effect of mid-follicular phase recombinant LH versus urinary HCG supplementation in poor ovarian responders undergoing IVF - a prospective double-blinded randomized study","volume":"34","author":"Mak","year":"2017","journal-title":"Reproductive Biomedicine Online"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.fertnstert.2013.01.095","article-title":"Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments","volume":"99","author":"Maldonado","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.fertnstert.2005.01.139","article-title":"Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation","volume":"84","author":"Malmusi","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1472-6483(10)60957-1","article-title":"GnRH antagonist in IVF poor-responder patients: results of a randomized trial","volume":"11","author":"Marci","year":"2005","journal-title":"Reproductive Biomedicine Online"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1472-6483(10)60513-5","article-title":"Randomized trial to compare the effect of recombinant human FSH (follitropian alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment","volume":"8","author":"Marrs","year":"2004","journal-title":"Reproductive Biomedicine Online"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/09513590801893331","article-title":"Prospective, randomized, comparative study of leuprorelin + human menopausal gonadotropins versus ganirelix + recombinant follicle-stimulating hormone in oocyte donors and pregnancy rates among the corresponding recipients","volume":"24","author":"Mart\u00ednez","year":"2008","journal-title":"Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.fertnstert.2010.02.059","article-title":"Randomized, comparative pilot study of pituitary suppression with depot leuprorelin versus cetrorelix acetate 3 mg in gonadotropin stimulation protocols for oocyte donors","volume":"94","author":"Martinez","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.rbmo.2009.09.016","article-title":"Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: a randomized controlled study","volume":"19","author":"Matorras","year":"2009","journal-title":"Reproductive Biomedicine Online"},{"issue":"Suppl","key":"10.1002\/14651858.CD012586.pub2-BIB0231|cit231","first-page":"i126","article-title":"Comparison of in vitro fertilization (IVF) outcomes in patients treated with hMG vs. recombinant FSH in their first IVF cycle","volume":"21","author":"Mayenga","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0232|cit232","first-page":"799","article-title":"Recombinant FSH vs. urinary FSH for ovarian stimulation in in vitro fertilization","volume":"48","author":"Meden-Vrtovec","year":"2003","journal-title":"Journal of Reproductive Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0233|cit233","first-page":"2010","article-title":"The effects of letrozole+GnRH antagonist versus mere GNRH antagonist during IVF in patients with poor ovarian response","volume":"14","author":"Mehrabian","year":"2021","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.fertnstert.2009.05.005","article-title":"A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization","volume":"94","author":"Melo","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/j.fertnstert.2015.07.1008","article-title":"A comparison of the efficacy and safety of combined highly purified human menopausal gonadotropin (HP-hMG) and highly purified urinary follicle stimulating hormone (HP-uFSH) versus HP-hMG alone for ovarian stimulation","volume":"104 Suppl","author":"Miller","year":"2015","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0236|cit236","first-page":"283","article-title":"Comparison between HP-FSH and HMG for superovulation in women undergoing in vitro fertilization","volume":"20","author":"Miron","year":"1998","journal-title":"Journal of Obstetrics & Gynaecology Canada"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/humrep\/deaa336","article-title":"Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders","volume":"36","author":"Moffat","year":"2021","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.fertnstert.2005.10.049","article-title":"Urinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study","volume":"85","author":"Mohamed","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/09513590500519260","article-title":"Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoing in vitro fertilization","volume":"22","author":"Mohamed","year":"2006","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/09513590.2012.730569","article-title":"Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI","volume":"29","author":"Mohsen","year":"2013","journal-title":"Gynecological Endocrinology"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0241|cit241","first-page":"653","article-title":"Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: a double-blind randomized clinical trial","volume":"17","author":"Moini","year":"2019","journal-title":"International Journal of Reproductive BioMedicine"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0242|cit242","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s43043-023-00153-7","article-title":"The effect of letrozole as an adjunct in GnRH-antagonist protocol on IVF\/ICSI outcome in women with endometriosis: a randomized clinical trial","volume":"28","author":"Mojtahedi Maryam","year":"2023","journal-title":"Middle East Fertility Society Journal"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0243|cit243","first-page":"148","article-title":"ART outcomes in GnRH antagonist protocol (flexible) and long GnRH agonist protocol during early follicular phase in patients with polycystic ovary syndrome: a randomized clinical trial","volume":"16","author":"Mokhtar","year":"2015","journal-title":"Journal of Reproduction and Infertility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0244|cit244","first-page":"i122","article-title":"GnRH antagonist plus hCG versus GnRH agonist short protocol in patients at risk for poor ovarian response","volume":"20","author":"Mollo","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12325-008-0028-8","article-title":"Comparison of GnRH agonists and antagonists in normoresponder IVF\/ICSI in Turkish female patients","volume":"25","author":"Moraloglu","year":"2008","journal-title":"Advances in Therapy"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.fertnstert.2003.11.031","article-title":"A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization","volume":"81","author":"Morgia","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"147","DOI":"10.15296\/ijwhr.2020.23","article-title":"A comparison of 3 different controlled ovarian stimulation protocols in poor women responders chosen according to POSEIDON criteria: micro-dose, standard flare-up, and antagonist protocol","volume":"8","author":"Muhammad","year":"2019","journal-title":"International Journal of Women's Health and Reproduction Sciences"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/0974-1208.101014","article-title":"Letrozole in a low-cost in vitro fertilization protocol in intracytoplasmic sperm injection cycles for male factor infertility: a randomized controlled trial","volume":"5","author":"Mukherjee","year":"2012","journal-title":"Journal of Human Reproductive Sciences"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/humrep\/der371","article-title":"The effect of recombinant LH on embryo quality: a randomized controlled trial in women with poor ovarian reserve","volume":"27","author":"Musters","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5539\/gjhs.v8n4p166","article-title":"Comparison of gnrh agonist microdose flare up and gnrh antagonist\/letrozole in treatment of poor responder patients in intra cytoplaspic sperm injection: randomized clinical trial","volume":"8","author":"Nabati","year":"2016","journal-title":"Global Journal of Health Science"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0251|cit251","first-page":"ii7","article-title":"A randomized controlled study of minimal stimulation IVF with two different protocols in normal responders","volume":"27 Suppl 2","author":"Nagulapally","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0252|cit252","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1447-0578.2007.00161.x","article-title":"Recombinant-follicle stimulating hormone is more effective than urinary human menopausal gonadotropin in ovarian hyperstimulation for assisted reproductive technology treatment","volume":"6","author":"Nakagawa","year":"2007","journal-title":"Reproductive Medicine & Biology"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0253|cit253","first-page":"49","article-title":"Efficacy of recombinant follicle stimulating hormone versus urinary follicle stimulating hormone in in-vitro fertilization: a prospective, randomized, assessor-blind study","volume":"12","author":"Nardo","year":"2000","journal-title":"Italian Journal of Gynaecology and Obstetrics"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/S0015-0282(01)02275-0","article-title":"Ovarian stimulation for in vitro fertilization (IVF): a prospective randomized comparison of recombinant FSH alone or in combination with human menopausal gonadotropins","volume":"76","author":"Nassar","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0255|cit255","unstructured":"A prospective, open label, randomised, parallel group, comparative pilot study to study the efficacy and safety of highly purified Menotrophin versus recombinant FSH (Follitropin alfa) administered subcutaneously to subfertile female patients undergoing IVF using antagonist downregulation. - PROSPECT http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2004-001307-35-GB 2005"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0256|cit256","unstructured":"A study of the efficacy and safety of highly purified menotrophin versus recombinant follitropin alfa https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00257556 2010"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0015-0282(16)59115-8","article-title":"Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization","volume":"47","author":"Neveu","year":"1987","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/humrep\/16.2.319","article-title":"HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial","volume":"16","author":"Ng","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0259|cit259","first-page":"i18","article-title":"A randomised trial (MERIT) comparing highly purified menotrophin and recombinant FSH in IVF","volume":"20","author":"Nyboe Andersen","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/humrep\/dem317","article-title":"Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial","volume":"23","author":"Nyboe Andersen","year":"2008","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl","key":"10.1002\/14651858.CD012586.pub2-BIB0261|cit261","first-page":"i54","article-title":"Addition of rLH (Luveris) to rFSH during the fiinal days of follicular maturation in IVF\/ICSI treated patients. A Nordic randomized multicentre trial","volume":"21","author":"Nyboe Andersen","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"sup1","key":"10.1002\/14651858.CD012586.pub2-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/09513590.2021.2006526","article-title":"IVF protocol efficacy in women with expected suboptimal response depending on ovary stimulation mode","volume":"37","author":"Ob'edkova","year":"2021","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0015-0282(99)00524-5","article-title":"Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)","volume":"73","author":"Olivennes","year":"2000","journal-title":"Fertility and Sterility"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/oxfordjournals.humrep.a135740","article-title":"A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization","volume":"10","author":"Out","year":"1995","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.rbmo.2009.05.007","article-title":"Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols","volume":"19","author":"Ozmen","year":"2009","journal-title":"Reproductive Biomedicine Online"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.fertnstert.2006.12.046","article-title":"GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization\/intracytoplasmic sperm injection cycles","volume":"88","author":"Pabuccu","year":"2007","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s10815-007-9159-0","article-title":"Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle","volume":"24","author":"Pacchiarotti","year":"2007","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.fertnstert.2010.04.035","article-title":"Urinary hMG (Meropur) versus recombinant FSH plus recombinant LH (Pergoveris) in IVF: a multicenter, prospective, randomized controlled trial","volume":"94","author":"Pacchiarotti","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/humrep\/des066","article-title":"GnRH-agonist versus GnRH-antagonist IVF cycles: Is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study","volume":"27","author":"Papanikolaou","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0270|cit270","first-page":"57","article-title":"The effect of four different gonadotropin protocols on oocyte and embryo quality and pregnancy outcomes in IVF\/ICSI cycles; a randomized controlled trial","volume":"42","author":"Parsanezhad","year":"2017","journal-title":"Iranian Journal of Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0271|cit271","first-page":"33, Abstract no","article-title":"Comparison between the GnRH antagonist ganirelix and the GnRH agonist buserelin: a prospective randomized controlled study","volume":"17","author":"Perino","year":"2002","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/09513590903215516","article-title":"LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels","volume":"26","author":"Pezzuto","year":"2010","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0273|cit273","first-page":"35","article-title":"Comparison pregnancy outcomes between minimal stimulation protocol and conventional GnRH antagonist protocols in poor ovarian responders","volume":"10","author":"Pilehvari","year":"2016","journal-title":"Journal of Family and Reproductive Health"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0274|cit274","first-page":"i119","article-title":"Prospective, blind, randomized evaluation of exogenous LH supplementation in the long GnRHa\/recFSH stimulation protocol for IVF\/ICSI","volume":"19","author":"Pournaropoulos","year":"2004","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/humrep\/deh832","article-title":"GnRH agonist versus GnRH antagonist in oocyte donation cycles: A prospective randomized study","volume":"20","author":"Prapas","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejogrb.2012.09.008","article-title":"GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial","volume":"166","author":"Prapas","year":"2013","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0277|cit277","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3109\/09513590.2012.665103","article-title":"A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: High efficacy and pregnancy rates","volume":"28","author":"Qiao","year":"2012","journal-title":"Gynecological Endocrinology"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0278|cit278","first-page":"1063","article-title":"Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol","volume":"17","author":"Rabati","year":"2012","journal-title":"Journal of Research in Medical Sciences"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/humrep\/14.6.1431","article-title":"Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome","volume":"14","author":"Raga","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"art 114","DOI":"10.1186\/1477-7827-10-114","article-title":"Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with compromised ovarian reserve: a randomised controlled non-inferiority trial","volume":"10","author":"Ragni","year":"2012","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0281|cit281","first-page":"281","article-title":"Role of LH administration during the follicular phase in women with risk of low response in ovarian stimulation with FSH and cetrorelix for IVF","volume":"23","author":"Ramirez","year":"2006","journal-title":"Revista Iberoamericana de Fertilidad y Reproduccion Humana"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejogrb.2004.11.007","article-title":"The effect of HMG and recombinant human FSH on oocyte quality: a randomized single-blind clinical trial","volume":"120","author":"Rashidi","year":"2005","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0015-0282(00)00469-6","article-title":"A prospective, randomized controlled trial comparing the efficacy of recombinant follicle-stimulating hormone in three different in vitro fertilization protocols","volume":"73","author":"Ravhon","year":"2000","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0284|cit284","first-page":"111","article-title":"Results from adding recombinant LH for assisted reproductive technology treatment: a randomized control trial","volume":"12","author":"Razi","year":"2014","journal-title":"Iranian Journal of Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0015-0282(16)57300-2","article-title":"Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Recombinant Human FSH Study Group","volume":"63","author":"Recombinant Human FSH Study Group","year":"1995","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10815-014-0227-y","article-title":"\"Mild\" vs. \"long\" protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial","volume":"31","author":"Revelli","year":"2014","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40618-013-0021-1","article-title":"Mild\/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome","volume":"37","author":"Rinaldi","year":"2014","journal-title":"Journal of Endocrinological Investigation"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.fertnstert.2006.06.059","article-title":"Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures","volume":"87","author":"Ruvolo","year":"2007","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0289|cit289","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.fertnstert.2014.12.062","article-title":"Human menopausal gonadotropin vs. mixed protocol (HMG\/FSH) in IVF\/PGS: effects on embryo quality and euploidy","volume":"103 Suppl 2","author":"Sabouni","year":"2015","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0015-0282(16)55322-9","article-title":"A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization","volume":"58","author":"San Roman","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1472-6483(10)61631-8","article-title":"Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction","volume":"9","author":"Sauer","year":"2004","journal-title":"Reproductive Biomedicine Online"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.fertnstert.2005.02.046","article-title":"Short versus long gonadotropin-releasing hormone analogue suppression protocols for superovulation in patients >=40 years old undergoing intracytoplasmic sperm injection","volume":"84","author":"Sbracia","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.fertnstert.2008.02.165","article-title":"Cetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracytoplasmic sperm injection patients older than 40","volume":"91","author":"Sbracia","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/humrep\/15.8.1691","article-title":"Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH","volume":"15","author":"Schats","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"S262 P","DOI":"10.1016\/j.fertnstert.2011.07.1003","article-title":"A controlled trial between natural cycle versus minimal stimulation in poor responder women: minimal stimulation works better in patients less than 40 years old","volume":"96 Suppl","author":"Schimberni","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"20","key":"10.1002\/14651858.CD012586.pub2-BIB0296|cit296","first-page":"4354","article-title":"Short gonadotropin-releasing hormone agonist versus flexible antagonist versus clomiphene citrate regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"20","author":"Schimberni","year":"2016","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0297|cit297","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.fertnstert.2004.10.053","article-title":"A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders","volume":"83","author":"Schmidt","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0298|cit298","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0015-0282(02)04202-4","article-title":"Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality","volume":"78","author":"Selman","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.fertnstert.2009.10.005","article-title":"Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome","volume":"94","author":"Selman","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.fertnstert.2006.02.110","article-title":"Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial","volume":"86","author":"Serafini","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012586.pub2-BIB0301|cit301","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0015-0282(03)01903-4","article-title":"Comparison of daily ganirelix administration to a long protocol agonist for controlled ovarian hyperstimulation in oocyte donors: the results of a prospective randomized controlled trial","volume":"80","author":"Shamma","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0302|cit302","doi-asserted-by":"publisher","first-page":"146","DOI":"10.21037\/atm.2019.04.16","article-title":"Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing in vitro fertilization-embryo transfer: a multi-center randomized controlled trial","volume":"7","author":"Shu","year":"2019","journal-title":"Annals of Translational Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s43032-021-00683-3","article-title":"A randomized controlled trial on the efficacy and safety of low-dose HCG in a short protocol with GnRH agonist and ovarian stimulation with recombinant FSH (rFSH) during the follicular phase in infertile women undergoing ART","volume":"29","author":"Siristatidis","year":"2022","journal-title":"Reproductive Sciences (Thousand Oaks, Calif.)"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0304|cit304","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/oxfordjournals.humrep.a019508","article-title":"A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme","volume":"11","author":"S\u00f6derstr\u00f6m-Anttila","year":"1996","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0305|cit305","first-page":"161","article-title":"Comparison of ART outcomes between two COH protocols: Gonal-F versus Gonal-F plus HMG","volume":"3","author":"Sohrabvand","year":"2010","journal-title":"International Journal of Fertility & Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0306|cit306","first-page":"229","article-title":"Comparison of highly purified urinary versus recombinant FSH: effect on ART outcomes in polycystic ovary syndrome","volume":"10","author":"Sohrabvand","year":"2012","journal-title":"Iranian Journal of Reproductive Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0015-0282(00)01696-4","article-title":"Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome","volume":"75","author":"Strehler","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0308|cit308","first-page":"109, Abstract n","article-title":"Personalized GnRH antagonist protocol versus GnRH agonist flare-up in patients at risk for poor ovarian response","volume":"18","author":"Strina","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012586.pub2-BIB0309|cit309","first-page":"61","article-title":"In IVF, administration of recombinant FSH (Puregon) gives a significantly higher mean number of oocytes, fertilized oocytes and good embryos compared with administration of purified urinary FSH (Metrodin)","volume":"9","author":"Sunde","year":"1994","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0310|cit310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fertnstert.2013.09.035","article-title":"Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"101","author":"Sunkara","year":"2014","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0311|cit311","first-page":"S11; O","article-title":"The administration of gonadotropin releasing hormone agonists to all patients undergoing in vitro fertilization is of no significant advantage: a prospective randomized study of 308 patients in their first cycle of IVF (ABSTRACT)","volume":"54","author":"Tan","year":"1991","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0312|cit312","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0015-0282(16)54963-2","article-title":"The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization","volume":"57","author":"Tan","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/humrep\/dei293","article-title":"The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study","volume":"21","author":"Tarlatzis","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0314|cit314","unstructured":"Randomized study stimulation of the ovaries in women with poor response expected or ovaries http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2013-002027-42-ES 2013"},{"issue":"e4l, 0375672","key":"10.1002\/14651858.CD012586.pub2-BIB0315|cit315","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejogrb.2018.10.034","article-title":"Ovarian stimulation with corifollitropin alfa followed by hp-hMG compared to hp-hMG in patients at risk of poor ovarian response undergoing ICSI: A randomized controlled trial","volume":"231","author":"Taronger","year":"2018","journal-title":"European Journal of Obstetrics, Gynecology, and Geproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0316|cit316","doi-asserted-by":"publisher","first-page":"386","DOI":"10.52547\/rbmb.11.3.386","article-title":"Evaluation of the effect of letrozole in the ovarian hyperstimulation syndrome prevention in participants at risk of treatment with ovulation-stimulating drugs: a randomized controlled trial","volume":"11","author":"Ghasemi Tehrani","year":"2022","journal-title":"Reports of Biochemistry & Molecular Biology"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0317|cit317","first-page":"165","article-title":"Flexible, multi-dose GnRH antagonist versus long GnRH agonist protocol in poor responders: a randomized controlled trial","volume":"2","author":"Tehraninejad","year":"2009","journal-title":"International Journal of Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0318|cit318","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00404-010-1429-x","article-title":"Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients","volume":"282","author":"Tehraninejad","year":"2010","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0319|cit319","first-page":"171","article-title":"GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran","volume":"9","author":"Tehraninejad","year":"2011","journal-title":"Iranian Journal of Reproductive Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0320|cit320","first-page":"435","article-title":"Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF\/ICSI cycles: an RCT","volume":"15","author":"Tehraninejad","year":"2017","journal-title":"International Journal of Reproductive BioMedicine"},{"issue":"12","key":"10.1002\/14651858.CD012586.pub2-BIB0321|cit321","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1093\/humrep\/17.12.3129","article-title":"Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence","volume":"17","author":"Tesarik","year":"2002","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0322|cit322","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.fertnstert.2003.09.077","article-title":"Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles","volume":"81","author":"Platteau","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0323|cit323","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(02)03250-8","article-title":"Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization\/intracytoplasmic sperm injection cycles: a randomized, comparative trial","volume":"78","author":"The European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0324|cit324","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","article-title":"Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation","volume":"16","author":"The European and Middle East Ogalutran Study Group","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0325|cit325","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1093\/humrep\/des256","article-title":"A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization","volume":"27","author":"Thuesen","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0326|cit326","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/humrep\/deu294","article-title":"Mental distress and personality in women undergoing GnRH agonist versus GnRH antagonist protocols for assisted reproductive technology","volume":"30","author":"Stenbaek","year":"2015","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0327|cit327","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/humrep\/dew051","article-title":"Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles","volume":"31","author":"Toftager","year":"2016","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0328|cit328","first-page":"556","article-title":"Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols","volume":"32","author":"Toftager","year":"2017","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0329|cit329","doi-asserted-by":"crossref","first-page":"265","DOI":"10.17772\/gp\/62205","article-title":"Flexible GnRH antagonist protocol vs. long GnRH agonist protocol in patients with polycystic ovary syndrome treated for IVF: comparison of clinical outcome and embryo quality","volume":"87","author":"Trenki","year":"2016","journal-title":"Ginekologia Polska"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0330|cit330","doi-asserted-by":"crossref","first-page":"101643","DOI":"10.1016\/j.jogoh.2019.101643","article-title":"The role of letrozole (LE) in controlled ovarian stimulation (COS) in patients at high risk to develop ovarian hyper stimulation syndrome (OHSS). A prospective randomized controlled pilot study","volume":"49","author":"Tshzmachyan","year":"2019","journal-title":"Journal of Gynecology Obstetrics and Human Reproduction"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0015-0282(16)55264-9","article-title":"Randomised prospective comparison of luteal leuprolide acetate and gonadotropins in 408 first cycles of in vitro fertilisation","volume":"58","author":"Tummon","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0332|cit332","first-page":"238","article-title":"Human menopausal gonadotropin versus recombinant FSH in polycystic ovary syndrome patients undergoing in vitro fertilization","volume":"6","author":"Turkcapar","year":"2013","journal-title":"International Journal of Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0333|cit333","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF01130591","article-title":"Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study","volume":"7","author":"de-Helder","year":"1990","journal-title":"Journal of in Vitro Fertilization and Embryo Transfer"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0334|cit334","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1472-6483(10)60611-6","article-title":"Aromatase inhibitors in ovarian stimulation for IVF\/ICSI: a pilot study","volume":"13","author":"Verpoest","year":"2006","journal-title":"Reproductive Biomedicine Online"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0335|cit335","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/1389201018666170808130526","article-title":"Gonadotropin releasing hormone agonists or antagonists for preimplantation genetic diagnosis (PGD)? A prospective randomised trial","volume":"18","author":"Verpoest","year":"2017","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0336|cit336","first-page":"S371","article-title":"Flare-up GnRH agonist versus GnRH antagonist protocol in poor responders undergoing IVF\/ICSI: a randomized controlled trial in Vietnam","volume":"107","author":"Viet Tien","year":"2009","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0337|cit337","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1472-6483(10)61868-8","article-title":"Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles - A prospective, randomized study","volume":"7","author":"Vlaisavljevic","year":"2003","journal-title":"Reproductive Biomedicine Online"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0338|cit338","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/humrep\/dev038","article-title":"Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged \u2265 35 years: a randomized controlled trial","volume":"30","author":"Vuong","year":"2015","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0339|cit339","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.fertnstert.2004.07.308","article-title":"Gonadotropin Releasing Hormone (GnRH) antagonist versus Microdose GnRH agonist flare for in vitro fertilization (IVF) cycles in women 39 - 42 years old with normal follicle stimulating hormone (FSH) levels","volume":"82","author":"Weckstein","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0340|cit340","unstructured":"Feichtinger W Kindermann C Pohl M Krischker U Hohlagschwandtner M Weigert M Clomid in combination with recombinant FSH and recombinant LH, versus the GNRHA-long protocol. A prospective randomized study on two different stimulations for IVF 11th World Congress on In Vitro Fertilization and Human Reproductive Genetics, Sydney, Australia, 9-14 May 1999 134"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0341|cit341","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0015-0282(02)03174-6","article-title":"Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study","volume":"78","author":"Weigert","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0342|cit342","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0015-0282(01)01973-2","article-title":"Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study","volume":"76","author":"Westergaard","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD012586.pub2-BIB0343|cit343","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.fertnstert.2019.02.049","article-title":"Association between the number of oocytes retrieved and cumulative live birth rate in IVF treatment: menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial outcomes","volume":"111","author":"Daftary","year":"2019","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.fertnstert.2018.07.106","article-title":"Can treatment of patients predicted to be high-responders be improved? Insights from the menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial","volume":"110","author":"Doody","year":"2018","journal-title":"Fertility and Sterility. Conference: 74th Annual Congress of the American Society for Reproductive Medicine, ASRM 2018. Denver Colorado, United States"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0345|cit345","first-page":"16","article-title":"Predicted high-responder women diagnosed with oligoovulation may benefit from stimulation with highly purified human menopausal gonadotrophin (HP-hMG)","volume":"35","author":"Heiser","year":"2020","journal-title":"Human Reproduction. Conference"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0346|cit346","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/j.fertnstert.2020.08.280","article-title":"Differential ovarian response to gonadotropin preparations despite similar ovarian reserve: menopur in GnRH (gonadotropin releasing hormone) antagonist single embryo transfer - high responder (MEGASET-HR) trial analysis","volume":"114","author":"Khair","year":"2020","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0347|cit347","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2020.03.029","article-title":"Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection","volume":"114","author":"Witz","year":"2020","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0348|cit348","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejogrb.2004.11.005","article-title":"A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy","volume":"120","author":"Xavier","year":"2005","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0349|cit349","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/CLEP.S226414","article-title":"Comparison between PPOS and GnRHa-long protocol in clinical outcome with the first IVF\/ICSI cycle: a randomized clinical trial","volume":"12","author":"Xi","year":"2020","journal-title":"Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0350|cit350","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/humrep\/deaa086","article-title":"The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study","volume":"35","author":"Xu","year":"2020","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0351|cit351","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12905-023-02473-2","article-title":"Introduce an optimal method of ovarian stimulation in the polycystic ovarian syndrome affected: a randomized controlled trial","volume":"23","author":"Yahyaei","year":"2023","journal-title":"BMC Women's Health"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0352|cit352","first-page":"452","article-title":"Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization","volume":"55","author":"Yang","year":"1995","journal-title":"Chung Hua I Hsueh Tsa Chih - Chinese Medical Journal"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0353|cit353","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1447-0756.1996.tb00955.x","article-title":"The evaluation of a new 7-day gonadotropin-releasing hormone agonist protocol in the controlled ovarian hyperstimulation for in vitro fertilization","volume":"22","author":"Yang","year":"1996","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0354|cit354","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12958-019-0483-x","article-title":"Letrozole supplementation during controlled ovarian stimulation in expected high responders: a pilot randomized controlled study","volume":"17","author":"Yang","year":"2019","journal-title":"Reproductive Biology and Endocrinology: RB&E"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0355|cit355","first-page":"98","article-title":"Evaluation of low-dose letrozole addition to ovulation induction in IVF","volume":"40","author":"Yasa","year":"2013","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"2-3","key":"10.1002\/14651858.CD012586.pub2-BIB0356|cit356","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10815-009-9300-3","article-title":"IVF\/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study","volume":"26","author":"Ye","year":"2009","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0357|cit357","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/09513590.2011.650742","article-title":"Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial","volume":"28","author":"Ye","year":"2012","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0358|cit358","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/cen.12886","article-title":"The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study","volume":"84","author":"Younis","year":"2016","journal-title":"Clinical Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0359|cit359","first-page":"112","article-title":"A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial","volume":"32","author":"Youssef","year":"2017","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0360|cit360","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1177\/0300060518770346","article-title":"Comparison of modified agonist, mild-stimulation and antagonist protocols for in vitro fertilization in patients with diminished ovarian reserve","volume":"46","author":"Yu","year":"2018","journal-title":"Journal of International Medical Research"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0361|cit361","doi-asserted-by":"crossref","first-page":"96.e1","DOI":"10.1016\/j.ajog.2015.08.009","article-title":"Minimal stimulation IVF vs conventional IVF: a randomized controlled trial","volume":"214","author":"Zhang","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0362|cit362","first-page":"i104","article-title":"Addition of recombinant human LH in IVF }ICSI cycles treated with Cetrotide: a randomised pilot study","volume":"19","author":"Zosmer","year":"2004","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0363|cit363","first-page":"117, Abstract n","article-title":"Prospective randomized trial of two mild ovarian stimulation protocols with recombinant FSH in combination with ganirelix acetate or low-dose leuprolide acetate: preliminary results","volume":"17","author":"Abae","year":"2002","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0364|cit364","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0015-0282(16)53343-3","article-title":"Comparative trial of luteinizing hormone-releasing hormone analog\/human menopausal gonadtropin and clomiphene citrate\/human menopausalgonadotropin in an assisted conception program","volume":"53","author":"Abdalla","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0365|cit365","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/humrep\/dex220","article-title":"A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials","volume":"32","author":"Abd-Elaziz","year":"2017","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0366|cit366","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10815-005-4911-9","article-title":"A prospective, randomized and blinded comparison between 10,000 IU urinary and 250 microg recombinant human chorionic gonadotropin for oocyte maturation in in vitro fertilization cycles","volume":"22","author":"Abdelmassih","year":"2005","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0367|cit367","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0015-0282(16)58631-2","article-title":"Recombinant follicle-stimulating hormone in the treatment of patients with history of severe ovarian hyperstimulation syndrome","volume":"66","author":"Aboulghar","year":"1996","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0368|cit368","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1472-6483(10)60339-2","article-title":"A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS","volume":"15","author":"Aboulghar","year":"2007","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0369|cit369","unstructured":"Abuzeid M Awadala A Bayer S Blauer K Cain K Check J A new presentation of Gonal-F (r-hFSH) filled by mass delivers more and better oocytes and embryos with a lower cumulative dose when compared with the current Follitropin alfa preparation in ovarian stimulation for ART 3rd World Congress on Controversies in Obstetrics, Gynecology & Infertility; 2002 June 20-23; Washington DC, USA Washington DC, USA 2002"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0370|cit370","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s10815-012-9850-7","article-title":"Early initiation of gonadotropin-releasing hormone antagonist in polycystic ovarian syndrome patients undergoing assisted reproduction: randomized controlled trial ISRCTN69937179","volume":"29","author":"Abuzeid","year":"2012","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0371|cit371","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/humrep\/den288","article-title":"A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation","volume":"23","author":"Abyholm","year":"2008","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0372|cit372","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.fertnstert.2006.05.049","article-title":"Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates","volume":"86","author":"Acevedo","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0373|cit373","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0015-0282(16)55564-2","article-title":"Prospective study of short and ultrashort regimens of gonadotropin-releasing hormone agonist in an in vitro fertilization program","volume":"58","author":"Acharya","year":"1992","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0374|cit374","unstructured":"Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=ACTRN12616001539426"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0375|cit375","doi-asserted-by":"publisher","first-page":"231","DOI":"10.29252\/ijrm.15.4.231","article-title":"Pregnancy outcome of \"delayed start\" GnRH antagonist protocol versus GnRH antagonist protocol in poor responders: a clinical trial study","volume":"15","author":"Aflatoonian","year":"2017","journal-title":"International Journal of Reproductive Biomedicine"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0376|cit376","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1023\/A:1022530420110","article-title":"The effects of gonadotropin-releasing hormone agonist on androstenedione production and follicular development during controlled ovarian hyperstimulation","volume":"15","author":"Akaboshi","year":"1998","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0377|cit377","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(01)02847-3","article-title":"Differential dose of antagonist (Ganirelix) relative to exogenous FSH","volume":"76","author":"Al-Inany","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"Suppl","key":"10.1002\/14651858.CD012586.pub2-BIB0378|cit378","first-page":"i25","article-title":"GnRH antagonist administration increases pregnancy rate in COH\/IUI cycles","volume":"21","author":"Allegra","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0379|cit379","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3109\/09513590.2010.526659","article-title":"Intrafollicular and serum levels of leptin during in vitro fertilization cycles: comparison between the effects of recombinant follicle-stimulating hormones and human menopausal gonadotrophin","volume":"27","author":"Almog","year":"2011","journal-title":"Gynecological Endocrinology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0380|cit380","first-page":"89, Abstract no","article-title":"Recombinant LH administration in down-regulated women with initial poor response to recombinant FSH","volume":"18","author":"Alviggi","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"45","key":"10.1002\/14651858.CD012586.pub2-BIB0381|cit381","first-page":"1","article-title":"A prospective, randomised, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing multifollicular ovarian stimulation in an ART programme (IVF)","volume":"5","author":"Alviggi","year":"2007","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0382|cit382","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/09513590.2013.788641","article-title":"A prospective, randomised, investigator-blind, controlled, clinical study on the clinical efficacy and tolerability of two highly purified hMG preparations administered subcutaneously in women undergoing IVF","volume":"29","author":"Alviggi","year":"2013","journal-title":"Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0383|cit383","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/humrep\/13.11.3023","article-title":"A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group","volume":"13","author":"The Ganirelix dose-findings Study Group","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0384|cit384","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/09513590009167664","article-title":"A prospective, randomized, controlled clinical study of a new subcutaneous, purified, urinary FSH preparation for controlled ovarian hyperstimulation in in vitro fertilization","volume":"14","author":"Anserini","year":"2000","journal-title":"Gynecological Endocrinology"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0385|cit385","first-page":"1035","article-title":"Stimulation in order to carry our in-vitro fertilisation using LHRH agonists. Comparison of the plasma and the intra-follicular hormone profiles using 'short' and 'long' profiles for treatment","volume":"19","author":"Antoine","year":"1990","journal-title":"Journal de Gynecologie, Obstetrique et Biologie de la Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0386|cit386","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/09513590.2015.1121227","article-title":"Successful use of 'hour 1' transfer of sperm microinjected oocytes in natural cycles of poor responder women: a prospective randomized controlled pilot study","volume":"32","author":"Aragona","year":"2016","journal-title":"Gynecological Endocrinology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0387|cit387","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.1016\/j.fertnstert.2005.07.837","article-title":"A pooled analysis of two large randomized trials comparing ongoing pregnancy rates with highly purified menotropin and recombinant FSH in IVF cycles","volume":"84","author":"Arce","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0388|cit388","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/09513590.2014.892066","article-title":"The rate of high ovarian response in women identified at risk by a high serum AMH level is influenced by the type of gonadotropin","volume":"30","author":"Arce","year":"2014","journal-title":"Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0389|cit389","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"102","author":"Arce","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0390|cit390","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rbmo.2020.07.006","article-title":"Establishing the follitropin delta dose that provides a comparable ovarian response to 150 IU\/day follitropin alfa","volume":"41","author":"Arce","year":"2020","journal-title":"Reproductive Biomedicine Online"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0391|cit391","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12958-018-0442-y","article-title":"Does the \"delayed start\" protocol with gonadotropin-releasing hormone antagonist improve the pregnancy outcome in Bologna poor responders? A randomized clinical trial","volume":"16","author":"Ashrafi","year":"2018","journal-title":"Reproductive Biology and Endocrinology: RB&E"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0392|cit392","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/j.fertnstert.2015.07.1016","article-title":"Early GNRH-antagonist initiation does not improve pregnancy rates of PCOS cases undergoing IVF\/ICSI: a prospective randomized study","volume":"104 Suppl","author":"Atabekoglu","year":"2015","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0393|cit393","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/09513599609027984","article-title":"Intranasal nafarelin versus buserelin (short protocol) for controlled ovarian hyperstimulation before in vitro fertilization: a prospective clinical trial","volume":"10","author":"Avrech","year":"1996","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0394|cit394","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tjog.2018.02.005","article-title":"Comparison of antagonist mild and long agonist protocols in terms of follicular fluid total antioxidant capacity","volume":"57","author":"Aydogan Mathyk","year":"2018","journal-title":"Taiwanese Journal of Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0395|cit395","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.fertnstert.2012.06.051","article-title":"Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: A randomized, controlled trial","volume":"98","author":"Baerwald","year":"2012","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0396|cit396","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0015-0282(16)55448-X","article-title":"The comparison of two gonadotropin-releasing hormone agonists in an in vitro fertilization program [published erratum appears in Fertil Steril 1993 May;59(5):1145] [see comments]","volume":"58","author":"Balasch","year":"1992","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0397|cit397","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejogrb.2019.07.032","article-title":"A multicenter, randomized, phase III study comparing the efficacy and safety of follitropin alpha biosimilar and the original follitropin alpha","volume":"241","author":"Barakhoeva","year":"2019","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0398|cit398","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/humrep\/14.5.1262","article-title":"Outcome of in-vitro fertilization through natural cycles in poor responders","volume":"14","author":"Bassil","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0399|cit399","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1009418017662","article-title":"A randomized prospective cross-over study of highly purified follicle- stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in women aged 37-41 years","volume":"17","author":"Bassil","year":"2000","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0400|cit400","doi-asserted-by":"crossref","first-page":"e2014.00128","DOI":"10.4293\/JSLS.2014.00128","article-title":"Comparison of ovulation induction protocols after endometrioma resection","volume":"18","author":"Bastu","year":"2014","journal-title":"JSLS: Journal of the Society of Laparoendoscopic Surgeons"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0401|cit401","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijgo.2015.05.034","article-title":"Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response","volume":"131","author":"Bayoumi","year":"2015","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0402|cit402","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/humrep\/15.1.43","article-title":"Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization","volume":"15","author":"Beckers","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0403|cit403","first-page":"i1 O","article-title":"Corifollitropin alfa versus recombinant FSH treatment for COS in a GnRH antagonist protocol: equal efficacy in terms of oocyte and embryo quality","volume":"24 Suppl 1","author":"Behr","year":"2009","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0404|cit404","first-page":"i239","article-title":"Luteinizing hormone supplementation from Day 1 versus 6 of ovarian stimulation in women aged 36n40 years: Results from an open-label, randomized, multicentre, multinational trial","volume":"28","author":"Behre","year":"2013","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0405|cit405","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.rbmo.2015.06.002","article-title":"Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation","volume":"31","author":"Behre","year":"2015","journal-title":"Reproductive Biomedicine Online"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0406|cit406","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/09513590.2012.730577","article-title":"Randomized controlled trial comparing highly purified (HP-hCG) and recombinant hCG (r-hCG) for triggering ovulation in ART","volume":"29","author":"Bellavia","year":"2013","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0407|cit407","first-page":"Article no: g77","article-title":"Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterine insemination with controlled ovarian hyperstimulation","volume":"350","author":"Bensdorp","year":"2015","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0408|cit408","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0015-0282(16)60012-2","article-title":"A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with Buserelin for superovulation and in vitro fertilization","volume":"50","author":"Bentick","year":"1988","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0409|cit409","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5152\/jtgga.2010.35","article-title":"Comparison of the ultrashort gonadotropin-releasing hormone agonist-antagonist protocol with microdose flare -up [sic] protocol in poor responders: a preliminary study","volume":"11","author":"Berker","year":"2010","journal-title":"Journal of the Turkish-German Gynecological Association"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0410|cit410","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.fertnstert.2020.09.158","article-title":"Individualized ovarian stimulation for in vitro fertilization: a multicenter, open label, exploratory study with a mixed protocol of follitropin delta and highly purified human menopausal gonadotropin","volume":"115","author":"Bissonnette","year":"2021","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0411|cit411","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1093\/humrep\/dep253","article-title":"Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study","volume":"24","author":"Blockeel","year":"2009","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0412|cit412","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.fertnstert.2011.01.028","article-title":"Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization\/intracytoplasmic sperm injection treatment cycle: Impact on ovarian stimulation. A pilot study","volume":"95","author":"Blockeel","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0413|cit413","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2010-2239","article-title":"Follicular phase endocrine characteristics during ovarian stimulation and gnrh antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5","volume":"96","author":"Blockeel","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0414|cit414","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/humrep\/deu105","article-title":"Administration of corifollitropin alfa on Day 2 versus Day 4 of the cycle in a GnRH antagonist protocol: a randomized controlled pilot study","volume":"29","author":"Blockeel","year":"2014","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012586.pub2-BIB0415|cit415","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.fertnstert.2004.02.028","article-title":"A comparison between a fixed versus a flexible GnRH protocol in IVF cycles","volume":"81","author":"Bonaventura","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0416|cit416","doi-asserted-by":"crossref","first-page":"i47 Abstract no","DOI":"10.1093\/humrep\/de.25.s1.32","article-title":"No difference in the cumulative pregnancy rates or live birth rates when comparing corifollitropin alfa with daily rFSH treatment for COS","volume":"25 Suppl 1","author":"Boostanfar","year":"2010","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0417|cit417","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.fertnstert.2012.02.038","article-title":"A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone","volume":"97","author":"Boostanfar","year":"2012","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0418|cit418","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.fertnstert.2015.04.018","article-title":"Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization","volume":"104","author":"Boostanfar","year":"2015","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0419|cit419","first-page":"61","article-title":"Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: a crossmatched pilot investigation of the optimal daily dose and timing","volume":"32","author":"Borgato","year":"2016","journal-title":"Gynecological Endocrinology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0420|cit420","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.fertnstert.2004.07.093","article-title":"The effectiveness of recombinant versus urinary human chorionic gonadotropin in IVF","volume":"82","author":"Borges","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0421|cit421","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/humrep\/det431","article-title":"Comment on 'Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years old or older undergoing IVF\/ICSI: a randomized controlled multicentre study'","volume":"29","author":"Bosch","year":"2014","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0422|cit422","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.rbmo.2018.10.012","article-title":"Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind phase 3 safety trial","volume":"38","author":"Bosch","year":"2018","journal-title":"Reproductive Biomedicine Online"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0423|cit423","first-page":"163","article-title":"Microdose flare-up gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols in poor ovarian responders undergoing intracytoplasmic sperm injection","volume":"17","author":"Boza","year":"2016","journal-title":"Journal of Reproduction & Infertility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0424|cit424","first-page":"70","article-title":"Gonal-F versus Puregon: results of a randomized, assessor-blind, comparitive study in women undergoing assisted reproductive technologies","volume":"13","author":"Brinsden","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0425|cit425","first-page":"S118","article-title":"Results of a randomised, assessor-blind clinical study comparing two preparations of recombinant human FSH in women undergoing assisted reproductive technologies (ART)","volume":"70","author":"Brinsden","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0426|cit426","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0015-0282(99)00450-1","article-title":"A comparison of the efficacy and tolerability of two recombinant human follicle-stimulating hormone preparations in patients undergoing in vitro fertilization-embryo transfer","volume":"73","author":"Brinsden","year":"2000","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0427|cit427","doi-asserted-by":"crossref","first-page":"4510; author re","DOI":"10.1210\/jc.2003-030807","article-title":"A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol[comment]","volume":"88","author":"Broekmans","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0428|cit428","unstructured":"Camier B A multicentre, prospective, randomised study to compare low dose protocol versus conventional administration of R-HFSH (Gonal-F) in normo-responders undergoing ART 1st Congress on Controversies in Obstetrics, Gynecology & Infertility, 1999 October 28-31, Prague 1999"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0429|cit429","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/humrep\/15.5.1009","article-title":"Consequences on gonadotrophin secretion of an early discontinuation of gonadotrophin-releasing hormone agonist administration in short-term protocol for in-vitro fertilization","volume":"15","author":"Cedrin-Durnerin","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0430|cit430","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1093\/humrep\/del259","article-title":"Timing of FSH administration for ovarian stimulation in normo-ovulatory women: comparison of an early or a mid follicular phase initiation of a short-term treatment","volume":"21","author":"Cedrin-Durnerin","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0431|cit431","first-page":"P475","article-title":"Comparison of superovulation characteristics and in vitro fertilization (IVF) outcomes between short and long protocols using gonadotropin-releasing hormone agonist (GNRH-A)","volume":"6","author":"Chang","year":"1991","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0432|cit432","first-page":"115","article-title":"Early discontinuation of gonadotropin-releasing hormone agonist in controlled ovarian hyperstimulation: a preliminary report","volume":"19","author":"Chang","year":"1996","journal-title":"Changgeng Yi Xue za Zhi [Chang Gung Medical Journal]"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0433|cit433","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5653\/cerm.2013.40.2.83","article-title":"Cessation of gonadotropin-releasing hormone antagonist on triggering day in flexible multiple-dose protocol: a randomized controlled study","volume":"40","author":"Chang","year":"2013","journal-title":"Clinical & Experimental Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0434|cit434","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/oxfordjournals.humrep.a137551","article-title":"Comparison of short versus long-term leuprolide acetate-human menopausal gonadotrophin hyperstimulation in in-vitro fertilization patients","volume":"7","author":"Check","year":"1992","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0435|cit435","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000292318","article-title":"Comparison of efficacy of high-dose pure follicle-stimulating hormone versus human menopausal gonadotropins for in vitro fertilization","volume":"40","author":"Check","year":"1995","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0436|cit436","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/humrep\/16.11.2473","article-title":"HMG is possibly superior to recombinant FSH for IVF","volume":"16","author":"Check","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0437|cit437","first-page":"102","article-title":"Presence of LH in gonadotropins associated with higher IVF pregnancy rates when basal serum LH is increased","volume":"28","author":"Check","year":"2001","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0438|cit438","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.12659\/MSM.913757","article-title":"Comparative effectiveness of three ovarian hyperstimulation protocol in in vitro fertilization (IVF) cycles for women with polycystic ovary syndrome","volume":"24","author":"Chen","year":"2018","journal-title":"Medical Science Monitor"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0439|cit439","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3389\/fendo.2019.00796","article-title":"Progestin vs. Gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surges in poor responders undergoing in vitro fertilization treatment: a randomized controlled trial","volume":"10","author":"Chen","year":"2019","journal-title":"Frontiers in Endocrinology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0440|cit440","unstructured":"Dosage of recombinant LH supplementation in women with previous unexpected hypo-response to conventional ovarian stimulation: a prospective, randomized, controlled, assessor-blind study https:\/\/www.chictr.org.cn\/showprojEN.html?proj=51712"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0441|cit441","unstructured":"The clinical outcome of HMG, HP-HMG, u-FSH and MPA used for ovarian stimulation in normalovulatory women https:\/\/www.chictr.org.cn\/showprojEN.html?proj=9571"},{"issue":"3 \/\/ *Mahidol U","key":"10.1002\/14651858.CD012586.pub2-BIB0442|cit442","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000367660","article-title":"Outcomes of follicle-stimulating hormone priming and nonpriming in in vitro maturation of oocytes in infertile women with polycystic ovarian syndrome: A single-blinded randomized study","volume":"79","author":"Choavaratana","year":"2015","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0443|cit443","unstructured":"Choi YS Jee BC Ku SY Suh CS Choi YM Kim JG Clinical efficacy of reduced dose GnRH agonist long protocol for controlled ovarian hyperstimulation in IVF-ET patients with high basal serum FSH level 5th World Congress on Controversies in Obstetrics, Gynecology & Infertility, 2004 June 3-6, Las Vegas, USA 2004"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0444|cit444","doi-asserted-by":"crossref","first-page":"S316","DOI":"10.1016\/j.fertnstert.2005.07.828","article-title":"Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3 and IGFBP-4 concentrations and their ratios between GnRH agonist long protocol and GnRH antagonist multiple-dose protocol for controlled ovarian hyperstimulation (COH) in in vitro fertilization and embryo transfer (IVF-ET)","volume":"84","author":"Choi","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0445|cit445","first-page":"72","article-title":"A step-up versus step-down protocol in polycystic ovaries. Randomized controlled multicentre study using recombinant FSH (Puregon)","volume":"16","author":"Christin","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0446|cit446","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/deg336","article-title":"A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome","volume":"18","author":"Christin-Maitre","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0447|cit447","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0015-0282(97)00423-8","article-title":"Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group","volume":"69","author":"Coelingh-Bennink","year":"1998","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0448|cit448","first-page":"216","article-title":"Embryonic quality in the use of urofolitropin vs recombinant FSH for in vitro fertilization [Spanish]","volume":"67","author":"Contreras-Bretherton","year":"1999","journal-title":"Ginecologia y Obstetricia de Mexico"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0449|cit449","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/humrep\/den288","article-title":"A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation","volume":"23","author":"Corifollitropin Alfa Dose-finding Study Group","year":"2008","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0450|cit450","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rbmo.2010.03.019","article-title":"Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women","volume":"21","author":"Corifollitropin Alfa Ensure Study Group","year":"2010","journal-title":"Reproductive Biomedicine Online"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0451|cit451","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.fertnstert.2004.01.022","article-title":"A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years","volume":"81","author":"D'Amato","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0452|cit452","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/09513590.2015.1092136","article-title":"Which is the best IVF\/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial","volume":"32","author":"Dakhly","year":"2016","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0453|cit453","first-page":"78","article-title":"Comparison of coasting with cabergoline administration for prevention of early severe OHSS in ART cycles","volume":"121","author":"Dalal","year":"2014","journal-title":"BJOG"},{"issue":"12","key":"10.1002\/14651858.CD012586.pub2-BIB0454|cit454","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/humrep\/16.12.2563","article-title":"Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK","volume":"16","author":"Daya","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0455|cit455","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2265.2004.02027.x","article-title":"Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation","volume":"60","author":"De Placido","year":"2004","journal-title":"Clinical Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0456|cit456","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1210\/jc.2003-031766","article-title":"Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization","volume":"89","author":"Devroey","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"12","key":"10.1002\/14651858.CD012586.pub2-BIB0457|cit457","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol","volume":"24","author":"Devroey","year":"2009","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0458|cit458","first-page":"i81","article-title":"Ovarian hyperstimulation syndrome, pregnancy, live birth and IVF cycle failure by risk category","volume":"30","author":"Devroey","year":"2015","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0459|cit459","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/oxfordjournals.humrep.a136039","article-title":"Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicullar stimulation in assisted reproduction","volume":"10","author":"Dhont","year":"1995","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0460|cit460","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.humrep.a137306","article-title":"Combination of long and short term GnRH analogue protocols: a new therapeutic approach to persistent high progesterone levels in IVF cycles","volume":"6","author":"Dicker","year":"1991","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0461|cit461","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/humrep\/14.Suppl_3.62","article-title":"Cessation of gonadotrophin-releasing hormone analogue (GnRHa) upon down-regulation versus conventional long GnRHa protocol in poor responders undergoing in-vitro fertilization","volume":"14","author":"Dirnfeld","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0462|cit462","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/oxfordjournals.humrep.a019292","article-title":"A combination of norethindrone acetate and leuprolide acetate blocks the gonadotrophin releasing hormone agonistic response and minimzes cyst formation during ovarian stimulation","volume":"11","author":"Ditkoff","year":"1996","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0463|cit463","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/humrep\/15.6.1305","article-title":"A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation","volume":"15","author":"Driscoll","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0464|cit464","unstructured":"During V von Kahn JA Sunde A Kjotrod SB Vainio T Results of a prospective,randomized study comparing two recombinant FSH preparations (Gonal-f, Puregon) in IVF and ICSI treatments 11th World Congress on In Vitro Fertilization and Human Reproductive Genetics, Sydney, Australia, 9-14 May 1999 265"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0465|cit465","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1016\/j.fertnstert.2004.07.612","article-title":"Comparison between two protocols of ovarian stimulation using a depot formulation of GnRH-agonist and a fixed-dose regimen of recombinant FSH: a prospective randomized study","volume":"82","author":"Dzik","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0466|cit466","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/humrep\/17.8.2022","article-title":"Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'?","volume":"17","author":"Engel","year":"2002","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0467|cit467","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0015-0282(98)00043-0","article-title":"Local side effects of subcutaneous and stimulation in in vitro fertilization: a prospective, randomized study","volume":"69","author":"Engmann","year":"1998","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0468|cit468","unstructured":"A phase III, randomized, double-blind, active-controlled, non-inferiority clinical trial to investigate the efficacy and safety of a single injection of Org 36286 (corifollitropin alfa) to induce multifollicular development for controlled ovarian stimulation using daily recombinant FSH as a reference https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2004-004771-11\/DK"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0469|cit469","unstructured":"A randomised study comparing two different regimens of ovarian stimulation using pergoveris and cetrorelix for controlled ovarian superovulation in assisted conception treatment. Pergoveris and cetrorelix for controlled ovarian stimulation https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2009-012847-40"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0470|cit470","unstructured":"A Phase III assessor-blinded randomised parallel group multi-centre study to compare efficacy and safety of two r-hFSH formulations (AFOLIA vs Gonal-f\u00ae) in women for assisted reproductive treatment - FIN3001 https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2010-019287-37"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0471|cit471","unstructured":"Prospective randomized trial concerning three different stimulation methods in IVF\/ICSI treatment in poor responders https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2012-001708-39\/BE"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0472|cit472","unstructured":"A study to assess two treatment regimes of injectable hormones, gonadotrophins, which are used to treat fertility problems in women, in the effectiveness of inducing egg stimulation in women who are unable to ovulate by themselves https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2012-003227-38"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0473|cit473","unstructured":"Comparative study between the usage of corifollitropin alfa and daily recombinant FSH in the ovarian stimulation of low responders https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2013-002979-17\/ES"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0474|cit474","unstructured":"Clinical study to compare the safety and effectiveness of Actavis rhFSH (the medicine being developed) with GONAL-f (an approved medicine) in stimulating multiple follicles (a woman's eggs or ova) in women participating in an assisted reproductive technology program (such as in vitro fertilisation, 'IVF') https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2013-003788-67"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0475|cit475","unstructured":"Reduction of progesterone elevation at trigger in poor responder Bologna criteria patients after controlled ovarian stimulation with long acting standard stimulation protocol compared with conventional daily protocol: a single center prospective randomized phase IV trial https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2020-004329-21\/IT"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0476|cit476","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1023\/B:JARG.0000006707.88826.e7","article-title":"Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF","volume":"20","author":"Fasouliotis","year":"2003","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0477|cit477","first-page":"P","article-title":"A comparative evaluation of elevated progesterone during the late follicular phase of patients treated with corifollitropin alfa or daily RFSH","volume":"27","author":"Fatemi","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl 1.1","key":"10.1002\/14651858.CD012586.pub2-BIB0478|cit478","first-page":"i77","article-title":"Ovarian stimulation with Corifollitropin alpha (CFA) for 7 days leads to reduced progesterone levels on the day of trigger and to higher ongoing pregnancy rates","volume":"32","author":"Fatemi","year":"2017","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0479|cit479","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1472-6483(11)60006-0","article-title":"Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF. [Reprint of Reprod Biomed Online. 2010 Nov;21(5):593-601; PMID: 20843746]","volume":"22 Suppl 1","author":"Fauser","year":"2011","journal-title":"Reproductive Biomedicine Online"},{"issue":"12","key":"10.1002\/14651858.CD012586.pub2-BIB0480|cit480","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3109\/09513590.2011.579661","article-title":"Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET*","volume":"27","author":"Fouda","year":"2011","journal-title":"Gynecological Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0481|cit481","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0015-0282(97)81458-6","article-title":"A prospective randomized comparison between long and discontinuous-long protocols of gonadotropin-releasing hormone agonist for in vitro fertilization","volume":"67","author":"Fujii","year":"1997","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0482|cit482","first-page":"175","article-title":"Comparison of different ovarian stimulation protocols in women with normal reserve. The role of the LH-recombinant","volume":"26","author":"Galindo","year":"2009","journal-title":"Revista Iberoamericana de Fertilidad y Reproduccion Humana"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0483|cit483","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1093\/humrep\/15.11.2292","article-title":"High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial","volume":"15","author":"Garcia-Velasco","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0484|cit484","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1472-6483(10)60340-9","article-title":"High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist. [Reprint in Reprod Biomed Online. 2011 Feb;22 Suppl 1:S52-9; PMID: 21575850]","volume":"15","author":"Garcia-Velasco","year":"2007","journal-title":"Reproductive Biomedicine Online"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0485|cit485","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.rbmo.2011.10.016","article-title":"Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial","volume":"24","author":"Garcia-Velasco","year":"2012","journal-title":"Reproductive Biomedicine Online"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0486|cit486","first-page":"35","article-title":"Comparison between follicular and luteal phase for starting depot GNRH analogue (goserelin) for pituitary suppression in IVF treatment","volume":"15","author":"Geber","year":"2001","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0487|cit487","first-page":"93","article-title":"Ovarian stimulation using a new highly purified urinary FSH: a prospective randomized clinical study","volume":"26","author":"Gerli","year":"1999","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"15","key":"10.1002\/14651858.CD012586.pub2-BIB0488|cit488","first-page":"2091","article-title":"Establishing a combined stimulation protocol hFSH followed by rFSH might represent a breakthrough in the IVF practice","volume":"17","author":"Gerli","year":"2013","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0489|cit489","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ijgo.12988","article-title":"Randomized controlled trial of gonadotropin-releasing hormone agonist microdose flare-up versus flare-up among poor responders undergoing intracytoplasmic sperm injection","volume":"148","author":"Ghaffari","year":"2020","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0490|cit490","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008528.pub2","article-title":"Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization","author":"Gibreel","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0491|cit491","first-page":"313","article-title":"Comparative, prospective, randomized study about the use of hp-HMG vs u-HMG in an egg donation program","volume":"21","author":"Giles","year":"2004","journal-title":"Revista Iberoamericana de Fertilidad y Reproduccion Humana"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0492|cit492","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.3892\/mmr.2015.3904","article-title":"Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: a cross-matched pilot investigation of the optimal daily dose and timing","volume":"12","author":"Gizzo","year":"2015","journal-title":"Molecular Medicine Reports"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0493|cit493","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ajog.2015.11.009","article-title":"Randomized controlled trial of minimal stimulation versus conventional in vitro fertilization (Letter to the Editor)","volume":"214","author":"Gleicher","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0494|cit494","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0015-0282(00)00605-1","article-title":"Subcutaneously administered Repronex in female patients undergoing in vitro fertilization is as effective and well tolerated as intramuscular menotropin treatment. Repronex SC, IVF Study Group","volume":"74","author":"Gocial","year":"2000","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0495|cit495","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejogrb.2006.05.025","article-title":"Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG","volume":"130","author":"Gomes","year":"2007","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0496|cit496","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1472-6483(10)61131-5","article-title":"LH improves early follicular recruitment in women over 38 years old","volume":"11","author":"G\u00f3mez-Palomares","year":"2005","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0497|cit497","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF01139780","article-title":"The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; Decapeptyl) and gonadotropins versus short-acting GnRH-a (Buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilisation (IVF)","volume":"8","author":"Gonen","year":"1991","journal-title":"Journal of in Vitro Fertilization and Embryo Transfer"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0498|cit498","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.rbmo.2019.09.003","article-title":"Fully human glyco-optimized recombinant FSH (follitropin epsilon) - a randomized, comparator-controlled phase II clinical trial","volume":"40","author":"Griesinger","year":"2020","journal-title":"Reproductive Biomedicine Online"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0499|cit499","first-page":"18","article-title":"Efficiency of antagonist IVF cycle programming by estrogens","volume":"38","author":"Guivarc'h-Leveque","year":"2010","journal-title":"Gynecologie Obstetrique Fertilit\u00e9"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0500|cit500","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.fertnstert.2007.07.327","article-title":"Late initiation of gonadotrophin administration after microdose flare up increases response in poor responders a randomized prospective study","volume":"88 Suppl 1","author":"Gunaydin","year":"2007","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0501|cit501","first-page":"ii302","article-title":"Does initiation of GnRH antagonists on cycle day 2 result in a more favourable follicular phase endocrine profile compared to initiation on cycle day 6","volume":"27 Suppl 2","author":"Hamdine","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0502|cit502","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.fertnstert.2013.05.031","article-title":"Early initiation of gonadotropin-releasing hormone antagonist treatment results in a more stable endocrine milieu during the mid- and late-follicular phases: a randomized controlled trial comparing gonadotropin-releasing hormone antagonist initiation on cycle day 2 or 6","volume":"100","author":"Hamdine","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"12","key":"10.1002\/14651858.CD012586.pub2-BIB0503|cit503","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/humrep\/det374","article-title":"Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial","volume":"28","author":"Hamdine","year":"2013","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0504|cit504","first-page":"i78","article-title":"Cumulative ongoing pregnancy and live birth rates following repeated controlled ovarian stimulation (COS) cycles using individualised follitropin delta dosing compared to conventional follitropin alfa dosing","volume":"32","author":"Havelock","year":"2017","journal-title":"Human Reproduction. Conference: 33rd Annual Meeting of the European Society of Human Reproduction and Embryology. Switzerland"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0505|cit505","first-page":"i2 O","article-title":"A comparison of corifollitropin vs. recombinant FSH in a GnRH antagonist protocol for controlled ovarian stimulation in women weighing 60 kg or less","volume":"24 Suppl 1","author":"Hillensjo","year":"2009","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0506|cit506","first-page":"i303","article-title":"Does treatment flexibility affect clinical outcome of either corifollitropin alfa or daily rFSH regimens?","volume":"26 Suppl 1","author":"Hillensjo","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0507|cit507","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/humrep\/11.suppl_5.123","article-title":"GnRH agonists and antagonists in ovarian stimulation","volume":"11 Suppl 1","author":"Hodgen","year":"1996","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0508|cit508","first-page":"222","article-title":"A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization","volume":"36","author":"Hong","year":"2001","journal-title":"Chinese Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0509|cit509","first-page":"84","article-title":"Pregnancy outcome of 'delayed start' GnRH antagonist protocol versus GnRH antagonist protocol in poor responders. Clinical trial study","volume":"15","author":"Hosseinisadat","year":"2017","journal-title":"International Journal of Reproductive BioMedicine"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0510|cit510","first-page":"141","article-title":"Fixed versus flexible gonadotropin releasing hormone antagonist protocol in controlled ovarian stimulation for invitro fertilization in women with polycystic ovary syndrome","volume":"9","author":"Hossein Rashidi","year":"2015","journal-title":"Journal of Family & Reproductive Health"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0511|cit511","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/humrep\/deg422","article-title":"Recombinant LH is equally effective as recombinant hCG in promoting oocyte maturation in a clinical in-vitro maturation programme: a randomized study","volume":"18","author":"Hreinsson","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0512|cit512","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/j.fertnstert.2016.07.558","article-title":"The ESPART randomized controlled trial in poor ovarian responders aligned with the Bologna criteria: a post hoc subgroup analysis according to poor ovarian response inclusion criteria","volume":"106","author":"Hubbard","year":"2016","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0513|cit513","unstructured":"Comparison of two protocols for ovarian stimulation in assisted reproductive technology https:\/\/irct.behdasht.gov.ir\/trial\/6867"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0514|cit514","unstructured":"Effect of GnRH-a and OCP on the result of IVF in females with moderate and severe endomethriosis https:\/\/irct.behdasht.gov.ir\/trial\/914"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0515|cit515","unstructured":"Letrozole effect in IVF cycles https:\/\/www.irct.ir\/trial\/53313"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0516|cit516","unstructured":"Effect of reduced dose of long-acting GnRH agonist versus short acting GnRH agonist https:\/\/irct.behdasht.gov.ir\/trial\/40173"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0517|cit517","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000064568","article-title":"A prospective comparative study on IVF outcomes with either purified FSH or human menopausal gonadotrophin in downregulated normogonadotrophic women","volume":"53","author":"Ismail","year":"2002","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0518|cit518","unstructured":"Comparison study of Puregon\u00ae and Elonva\u00ae used in a long gonadotropin-releasing hormone (GnRH) agonist protocol for IVF stimulation https:\/\/www.isrctn.com\/ISRCTN98623456"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0519|cit519","doi-asserted-by":"crossref","first-page":"S301","DOI":"10.1016\/j.fertnstert.2005.07.785","article-title":"A randomized study of recombinant versus urinary human chorionic gonadotrophin in Chinese women undergoing assisted reproductive technology cycles","volume":"84","author":"Jie","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0520|cit520","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1016\/j.fertnstert.2009.07.1579","article-title":"Diminished but significant mid-cycle LH surge can be induced in the long protocol of GnRH agonist and HMG regimen, resulting in a great increase in the rate of ongoing pregnancy","volume":"92 Suppl 1","author":"Jinno","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0521|cit521","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008528.pub3","article-title":"Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation","author":"Kamath","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0522|cit522","first-page":"319","article-title":"rFSH versus clomiphene citrate and HMG: results of a randomized comparative study in Indian infertile women","volume":"14","author":"Kannan","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0523|cit523","unstructured":"Comparison of IVF-ET outcomes with GnRH antagonist started either on stimulation day 1 and 6 vs. conventional GnRH agonist long protocol in patients with polycystic ovary syndrome https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=KCT0000157"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0524|cit524","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.fertnstert.2004.01.036","article-title":"Evaluation of mixed protocols with Bravelle (human-derived FSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization","volume":"82","author":"Keye","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0525|cit525","first-page":"18 Abstract no:","article-title":"Comparison of recombinant HCG with urinary HCG during ovulation induction cycles in infertile women undergoing assisted reproductive technology treatment","volume":"10 Suppl 1","author":"Khani","year":"2012","journal-title":"Iranian Journal of Reproductive Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0526|cit526","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.fertnstert.2009.06.005","article-title":"Minimal stimulation using gonadotropin-releasing hormone (GnRH) antagonist and recombinant human follicle-stimulating hormone versus GnRH antagonist multiple-dose protocol in low responders undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"92","author":"Kim","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0527|cit527","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1016\/j.fertnstert.2013.07.1111","article-title":"Corifollitropin alfa versus daily recombinant FSH treatment for controlled ovarian stimulation in poor responders","volume":"100 Suppl","author":"Kim","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0528|cit528","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2010.05.052","article-title":"Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial","volume":"95","author":"Kolibianakis","year":"2011","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0529|cit529","first-page":"i51","article-title":"Corifollitropin-alfa compared to daily rFSH in poor responders undergoing ICSI: a randomized clinical trial","volume":"29","author":"Kolibianakis","year":"2014","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0530|cit530","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0015-0282(16)58571-9","article-title":"A randomized prospective study of early follicular or midluteal initiation of long protocol gonadotropin-releasing hormone in an in vitro fertilization program","volume":"66","author":"Kondaveeti","year":"1996","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0531|cit531","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12978-018-0639-8","article-title":"A multi-center, randomized controlled clinical trial of the application of a shortened protocol of long-acting Triptorelin down-regulated prior to IVF\/ICSI among patients with endometriosis: a protocol","volume":"15","author":"Kong","year":"2018","journal-title":"Reproductive Health"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0532|cit532","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/humrep\/det432","article-title":"Reply: Comment on recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF\/ICSI: a randomized controlled multicentre study","volume":"29","author":"Konig","year":"2014","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0533|cit533","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.fertnstert.2007.06.080","article-title":"A comparison study of a novel stimulation protocol and the conventional low dose step-up and step-down regimens in patients with polycystic ovary syndrome undergoing in vitro fertilization","volume":"90","author":"Koundouros","year":"2008","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0534|cit534","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.fertnstert.2010.07.138","article-title":"Microdose flare-up versus antagonist protocols for poor responder patients: a meta-analysis","volume":"94","author":"Kovanci","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"12","key":"10.1002\/14651858.CD012586.pub2-BIB0535|cit535","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10815-007-9176-z","article-title":"Luteal start of exogenous FSH in poor responder women","volume":"24","author":"Kucuk","year":"2007","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0536|cit536","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1447-0756.2008.00750.x","article-title":"Efficiency of follicle-stimulating hormone, commenced in the luteal phase, for overcoming a poor response in assisted reproduction","volume":"34","author":"Kucuk","year":"2008","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0537|cit537","first-page":"i90 Abstract no","article-title":"Recombinant LH supplementation in patients with a relative reduction in lh levels during IVF\/ICSI cycles: a prospective randomised controlled trial","volume":"25 Suppl 1","author":"Lahoud","year":"2010","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0538|cit538","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejogrb.2017.01.011","article-title":"Recombinant LH supplementation in patients with a relatice reduction in LH levels during IVF\/ICSI cycles: a prospective randomized controlled trial","volume":"10","author":"Lahoud","year":"2017","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0539|cit539","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0015-0282(16)53335-4","article-title":"Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome","volume":"53","author":"Larsen","year":"1990","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0540|cit540","doi-asserted-by":"crossref","first-page":"661707","DOI":"10.3389\/fendo.2021.661707","article-title":"Step-down of FSH- dosage during ovarian stimulation - basic lessons to be learnt from a randomized controlled trial","volume":"12","author":"Lawrenz","year":"2021","journal-title":"Frontiers in Endocrinology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0541|cit541","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1477-7827-11-52","article-title":"Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial","volume":"11","author":"Leader","year":"2013","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0542|cit542","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejogrb.2005.11.023","article-title":"Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH","volume":"126","author":"Levi-Setti","year":"2006","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0543|cit543","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3109\/09513590.2013.813475","article-title":"Effect of delayed initiation of gonadotropin in luteal long protocol on in vitro fertilization","volume":"29","author":"Lin","year":"2013","journal-title":"Gynecological Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0544|cit544","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00404-003-0544-3","article-title":"Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations","volume":"270","author":"Loutradis","year":"2004","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0545|cit545","first-page":"20A","article-title":"Natural cycle in-vitro fertilization. Prospective, randomized trial comparing unstimulated with stimulated in-vitro fertilization (abstract)","volume":"96","author":"MacDougall","year":"1992","journal-title":"Journal of Reproduction and Fertility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0546|cit546","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0015-0282(16)56755-7","article-title":"Comparison of natural with clomiphene citrate-stimulated cycles in in vitro fertilization: a prospective, randomized trial [see comments]","volume":"61","author":"MacDougall","year":"1994","journal-title":"Fertility and Sterility"},{"issue":"12","key":"10.1002\/14651858.CD012586.pub2-BIB0547|cit547","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1177\/1933719115590666","article-title":"Delayed start versus conventional gnrh antagonist protocol in poor responders pretreated with estradiol in luteal phase: a randomized controlled trial","volume":"22","author":"Maged","year":"2015","journal-title":"Reproductive Sciences (Thousand Oaks, Calif.)"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0548|cit548","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1177\/1933719118756753","article-title":"Effect of prolonged GnRH agonist downregulation on ICSI outcome in patients with endometriomas of less than 5 cm: a randomized controlled trial","volume":"25","author":"Maged","year":"2018","journal-title":"Reproductive Sciences (Thousand Oaks, Calif.)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0549|cit549","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-0412.2003.820108.x","article-title":"The use of clomiphene citrate\/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF\/ICSI program is not a cost effective protocol","volume":"82","author":"Mansour","year":"2003","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0550|cit550","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/oxfordjournals.humrep.a138030","article-title":"Comparative trial between an ultra-short and long protocol of lutenizing hormone-releasing hormone agonist for ovarian stimulation in in-vitro fertilization","volume":"8","author":"Marcus","year":"1993","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0551|cit551","first-page":"i304 Abstract n","article-title":"Success rates of early responders to corifollitropin alfa or daily rFSH in a large, randomized, double-blind trial","volume":"26 Suppl 1","author":"Mardesic","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0552|cit552","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0015-0282(16)54368-4","article-title":"Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization","volume":"55","author":"Maroulis","year":"1991","journal-title":"Fertility and Sterility"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0553|cit553","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0015-0282(03)00106-7","article-title":"Evaluation of mixed protocols with Bravelle (hFSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE I) in patients (18-33 years) undergoing in vitro fertilization","volume":"79","author":"Marrs","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0554|cit554","first-page":"355","article-title":"Comparison of 'short protocol' versus 'antagonists' with or without clomiphene citrate for stimulation in IVF of patients with 'low response'","volume":"20","author":"Martinez","year":"2003","journal-title":"Revista Iberoamericana de Fertilidad y Reproduccion Humana"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0555|cit555","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2009.06.001","article-title":"GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study","volume":"19","author":"Melo","year":"2009","journal-title":"Reproductive Biomedicine Online"},{"issue":"52","key":"10.1002\/14651858.CD012586.pub2-BIB0556|cit556","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-015-0039-2","article-title":"Comparative prospective study of 2 ovarian stimulation protocols in poor responders: effect on implantation rate and ongoing pregnancy","volume":"12","author":"Merviel","year":"2015","journal-title":"Reproductive Health"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0557|cit557","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005070.pub3","article-title":"Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF\/ICSI cycles","author":"Mochtar","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0558|cit558","first-page":"S42","article-title":"The use of GnRH-a in a luteal suppression vs follicular \"flare-up\" in conjunction with gonadotropins for ovarian hyperstimulation for in vitro fertilisation (IVF) in patients with normal basal gonadotropin levels: a randomised prospective study","volume":"56","author":"Muasher","year":"1991","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0559|cit559","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1556\/ABiol.62.2011.3.5","article-title":"Impact of highly purified versus recombinant follicle stimulating hormone on oocyte quality and embryo development in intracytoplasmic sperm injection cycles","volume":"62","author":"Murber","year":"2011","journal-title":"Acta Biologica Hungarica"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0560|cit560","unstructured":"Corifollitropin alfa versus recombinant follicle stimulating hormone (FSH) in ovarian stimulation of women undergoing in vitro fertilisation https:\/\/clinicaltrials.gov\/show\/NCT01319695"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0561|cit561","unstructured":"An efficacy and safety study of corifollitropin alfa (MK-8962) in contrast to recombinant FSH for use in controlled ovarian stimulation of Indian women (p07056, also known as MK-8962-029) https:\/\/clinicaltrials.gov\/show\/NCT01599494"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0562|cit562","unstructured":"Phase III study comparing efficacy and safety of AFOLIA vs Gonal-f\u00ae RFF in women (35 to 42) undergoing IVF https:\/\/clinicaltrials.gov\/show\/NCT01687712"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0563|cit563","unstructured":"Corifollitropin alfa versus follitropin beta in high responders https:\/\/clinicaltrials.gov\/show\/NCT02471677"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0564|cit564","unstructured":"Comparative study of long-acting and short acting triptorelin in PCOS patients who underwent IVF\/ICSI https:\/\/clinicaltrials.gov\/show\/NCT02477566"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0565|cit565","unstructured":"Miniflare versus long protocol in poor responders https:\/\/clinicaltrials.gov\/show\/NCT02681536"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0566|cit566","unstructured":"Low-dose hCG as an adjunct to ovarian stimulation in subfertile women undergoing ART https:\/\/clinicaltrials.gov\/study\/NCT03423537"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0567|cit567","unstructured":"The effectiveness and safety of the prolonged down-regulation protocol for controlled ovarian hyperstimulation https:\/\/clinicaltrials.gov\/show\/NCT03809221"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0568|cit568","unstructured":"Impact of ultra-long versus long down-regulation protocol on IVF\/ICSI in adenomyosis https:\/\/clinicaltrials.gov\/show\/NCT03940807"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0569|cit569","unstructured":"Recombinant LH supplementation timing strategies (from day 1 or day 6) to a standard GnRH agonist long protocol in subsequent COS cycle of older patients with unexpected poor or suboptimal ovarian response https:\/\/clinicaltrials.gov\/show\/NCT04178135"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0570|cit570","unstructured":"FSH followed by HMG vs FSH plus HMG in IVF https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04385342"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0571|cit571","unstructured":"Cumulative pregnancy rate with lower and higher gonadotropin dose during IVF among poor responders clinicaltrials.gov\/show\/NCT05103228"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0572|cit572","first-page":"33","article-title":"GnRHa stop protocol versus long protocol in poor responder IVF patients","volume":"6","author":"Nejad","year":"2008","journal-title":"Iranian Journal of Reproductive Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0573|cit573","first-page":"471","article-title":"Prospective and randomized study about two models of ovaric stimulation for IVF under hypophysary inhibition with GnRH agonists","volume":"38","author":"Neyro","year":"1995","journal-title":"Progresos en Obstetricia y Ginecologia"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0574|cit574","first-page":"i315","article-title":"Efficacy and safety of follitropin delta in an individualised dosing regimen: A randomised, assessor-blind, controlled phase 3 trial in IVF\/ ICSI patients (ESTHER-1)","volume":"31","author":"Nyboe Andersen","year":"2016","journal-title":"Human Reproduction. Conference: 32nd Annual Meeting of the European Society of Human Reproduction and Embryology. Finland"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0575|cit575","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Nyboe Andersen","year":"2017","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0576|cit576","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rbmo.2010.03.019","article-title":"Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women","volume":"21","author":"Obruca","year":"2010","journal-title":"Reproductive Biomedicine Online"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0577|cit577","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0015-0282(97)81490-2","article-title":"Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins","volume":"68","author":"Out","year":"1997","journal-title":"Fertility and Sterility"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD012586.pub2-BIB0578|cit578","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1016\/j.fertnstert.2019.08.043","article-title":"Long-antagonist protocol; a new protocol where a bolus luteal dose of long-acting GnRH-antagonist degarelix can efficiently downregulate lh during ovarian stimulation for IVF Addressing flexibility in an antagonist protocol","volume":"112","author":"Papanikolaou","year":"2019","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0579|cit579","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.humrep.a136889","article-title":"Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotropin-releasing hormone analogues in different phases of the menstrual cycle","volume":"4","author":"Pellicer","year":"1989","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0580|cit580","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/humrep\/dem372","article-title":"Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint","volume":"23","author":"Polinder","year":"2008","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"10","key":"10.1002\/14651858.CD012586.pub2-BIB0581|cit581","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/humrep\/der240","article-title":"Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF. [Erratum appears in Hum Reprod. 2012 Apr;27(4):1230]","volume":"26","author":"Pu","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0582|cit582","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.rbmo.2015.01.005","article-title":"A multi-centre phase 3 study comparing efficacy and safety of Bemfola versus Gonal-f in women undergoing ovarian stimulation for IVF","volume":"30","author":"Rettenbacher","year":"2015","journal-title":"Reproductive Biomedicine Online"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0583|cit583","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10815-012-9804-0","article-title":"Outcome of in vitro fertilization in patients with proven poor ovarian responsiveness after early vs. mid-follicular LH exposure: a prospective, randomized, controlled study","volume":"29","author":"Revelli","year":"2012","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0584|cit584","unstructured":"Reyftmann L Dechaud H Serrour A Lacroix N Anahory T Loup V Modified natural cycle compared to a mild stimulated antagonist protocol, in poor responders under 38 years old First World Congress on National Cycle\/Minimal Stimulation IVF, 2006 December 15-16, London 2006"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0585|cit585","first-page":"28","article-title":"Short, semi-short or long GnRH agonist treatment regimens in women candidates of ICSI; Which is proper in preventing premature LH surge?","volume":"17","author":"Rezaeian","year":"2016","journal-title":"Journal of Reproduction and Infertility"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012586.pub2-BIB0586|cit586","doi-asserted-by":"crossref","first-page":"S69, Abstract n","DOI":"10.1016\/S0015-0282(03)01987-3","article-title":"Evaluation of mixed protocols with Bravelle (hFSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE): a comparison of patients 18-33 years and 34-40 years undergoing in vitro fertilization","volume":"80","author":"Rodriguez","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0587|cit587","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0015-0282(98)00018-1","article-title":"Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle","volume":"69","author":"Rombauts","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0588|cit588","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0015-0282(16)53695-4","article-title":"The comparison of early follicular and midluteal administration of long-acting gonadotropin-releasing hormone agonist","volume":"54","author":"Ron El","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0589|cit589","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0015-0282(16)54188-0","article-title":"Gonadotropins and combined gonadotropin-releasing hormone agonist--gonadotropins protocols in a randomized prospective study","volume":"55","author":"Ron El","year":"1991","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0590|cit590","first-page":"119","article-title":"A comparison of the use of clomiphene citrate and letrozole in patients undergoing IVF with the objective of producing only one or two embryos","volume":"7","author":"Rose","year":"2015","journal-title":"Facts Views & Vision in Obgyn"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0591|cit591","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0015-0282(16)54059-X","article-title":"A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome","volume":"55","author":"Sagle","year":"1991","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0592|cit592","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/j.fertnstert.2020.09.026","article-title":"Cost effective protocol with letrozole and three doses of gonadotropin combination as an alternative to continuous gonadotropin for ovulation induction for IUI in clomiphene citrate resistant PCOS patients - a RCT","volume":"114","author":"Saha","year":"2020","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0593|cit593","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/oxfordjournals.humrep.a136740","article-title":"Comparison between long and short protocols of LHRH agonist in the treatment of polycystic ovary disease by in-vitro fertilization","volume":"3","author":"Salat Baroux","year":"1988","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0594|cit594","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/09513590.2017.1416464","article-title":"A comparison of treatment results of the different treatment protocols in patients with poor ovarian response","volume":"34","author":"Sanverdi","year":"2018","journal-title":"Gynecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0595|cit595","doi-asserted-by":"crossref","first-page":"S1 Abstract no:","DOI":"10.1016\/j.fertnstert.2012.07.003","article-title":"Use of depot GnRH antagonist (Degarelix) in the ovarian stimulation in women with PCOS undergoing IVF. A controlled trial","volume":"98 Suppl 1","author":"Sbracia","year":"2012","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0596|cit596","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.fertnstert.2007.02.013","article-title":"Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist\/letrozole protocol?","volume":"89","author":"Schoolcraft","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0597|cit597","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2147\/IJWH.S117577","article-title":"Effectiveness of corifollitropin alfa used for ovarian stimulation of poor responder patients","volume":"8","author":"Selman","year":"2016","journal-title":"International Journal of Women's Health"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0598|cit598","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/09513590.2017.1296128","article-title":"Mild versus conventional antagonist ovarian stimulation protocols in expected normal responders undergoing IVF\/ICSI: a case-control study","volume":"33","author":"Siristatidis","year":"2017","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0599|cit599","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejogrb.2016.07.498","article-title":"Efficiency of mild ovarian stimulation with clomiphene on poor ovarian responders during IVF\\ICSI procedures: a meta-analysis","volume":"204","author":"Song","year":"2016","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0600|cit600","doi-asserted-by":"crossref","first-page":"S314","DOI":"10.1016\/j.fertnstert.2005.07.820","article-title":"Impact of a GnRH antagonist (Ganirelix\u00ae) on the outcome of controlled ovarian hyperstimulation (COH) in PCOS patients: a prospective and randomized study","volume":"84","author":"Stadtmauer","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0601|cit601","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/humrep\/12.7.1403","article-title":"Prospective randomized study of an ultrashort gonadotrophin-releasing hormone agonist versus a modified suppression protocol for ovarian stimulation in intracytoplasmic sperm injection cycles","volume":"12","author":"Strohmer","year":"1997","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0602|cit602","article-title":"Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)","volume":"14","author":"Strowitzki","year":"2016","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0603|cit603","first-page":"159","article-title":"Comparison of the effects and safety of mild ovarian stimulation and conventional ovarian stimulation with a long GnRH agonist protocol on IVF outcomes","volume":"24","author":"Tan","year":"2013","journal-title":"Journal of Reproduction and Contraception"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0604|cit604","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5935\/1518-0557.20220006","article-title":"Medroxyprogesterone acetate versus gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surge in hyper-responder women undergoing controlled ovarian stimulation for IVF\/ICSI cycles","volume":"27","author":"Tandulwadkar","year":"2022","journal-title":"JBRA Assisted Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0605|cit605","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/oxfordjournals.humrep.a138146","article-title":"Ovarian stimulation with buserelin\/HMG\/HCG: prospective randomized study of short versus long protocol","volume":"8","author":"Tarlatzis","year":"1993","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0606|cit606","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.rbmo.2012.01.005","article-title":"Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH","volume":"24","author":"Tarlatzis","year":"2012","journal-title":"Reproductive Biomedicine Online"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0607|cit607","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00404-008-0620-9","article-title":"Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"278","author":"Tazegul","year":"2008","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0608|cit608","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/j.fertnstert.2015.07.1003","article-title":"Comparison of hormonal levels in polycystic ovary patients using short and long antagonist protocols during controlled ovarian stimulation in IVF-ET cycles","volume":"104 Suppl","author":"Thakur","year":"2015","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0609|cit609","first-page":"146","article-title":"A randomised study comparing two regimen of ovarian stimulation using pergoveris and cetrorelix","volume":"32","author":"Thong","year":"2016","journal-title":"Gynecological Endocrinology"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0610|cit610","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/humrep\/14.11.2709","article-title":"Comparison of two recombinant follicle-stimulating hormone preparations in in-vitro fertilization: a randomized clinical study","volume":"14","author":"Tulppala","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0611|cit611","first-page":"209","article-title":"Comparison between 3 long protocols of ovarian stimulation for IVF using a long acting formulation of GnRH agonist","volume":"21","author":"Vauthier Brouzes","year":"1993","journal-title":"Contraception, Fertilit\u00e9, Sexualit\u00e9"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0612|cit612","first-page":"hox023","article-title":"Corifollitropin alfa vs recombinant FSH for controlled ovarian stimulation in women aged 35-42 years with a body weight \u226550 kg: a randomized controlled trial","volume":"3","author":"Vuong","year":"2017","journal-title":"Human Reproduction Open"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0613|cit613","first-page":"Article Number:","article-title":"Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (United States)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0614|cit614","first-page":"87","article-title":"The efficacy and safety of recombinant - versus urinary-human chorionic gonadotrophin in ovulation induction: results of a double-blind clinical study","volume":"15","author":"Warne","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0615|cit615","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0015-0282(02)04928-2","article-title":"Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization-embryo transfer","volume":"79","author":"Weissman","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0616|cit616","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1016\/j.fertnstert.2005.07.808","article-title":"A randomized prospective study comparing the use of a standard gnrh antagonist versus a 'long' antagonist protocol for controlled ovarian hyperstimulation prior to IVF","volume":"84","author":"Weissman","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0617|cit617","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/oxfordjournals.humrep.a019357","article-title":"The effect of human menopausal gonadotrophin and highly purified urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down regulated normogondotrophic woman","volume":"11","author":"Westergaard","year":"1996","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0618|cit618","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11596-019-2055-x","article-title":"Flexible GnRH antagonist protocol versus progestin-primed ovarian stimulation (PPOS) protocol in patients with polycystic ovary syndrome: comparison of clinical outcomes and ovarian response","volume":"39","author":"Xiao","year":"2019","journal-title":"Current Medical Science"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0619|cit619","first-page":"1081","article-title":"The use of a long-acting gonadotropin-releasing hormone analog(D-Trp-6-LHRH) for improvement of ovarian stimulation in assisted conception programs","volume":"90","author":"Yang","year":"1991","journal-title":"Journal of the Formosan Medical Association \/ Taiwan Yi Zhi"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0620|cit620","first-page":"222","article-title":"A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization","volume":"36","author":"Ye","year":"2001","journal-title":"Zhonghua Fu Chan Ke za Zhi"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0621|cit621","first-page":"63","article-title":"GnRH agonist long protocol versus short protocol in women 40 years or more undergoing ICSI: a multicenter study","volume":"13","author":"Youssef","year":"2008","journal-title":"Middle East Fertility Society Journal"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0622|cit622","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0623|cit623","first-page":"23","article-title":"Corifollitropin- alpha compared to daily r-FSH in for patients undergoing intracytoplasmic sperm injection: clinical trial study","volume":"17","author":"Zahiri Sorouri","year":"2019","journal-title":"International Journal of Reproductive Biomedicine"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0624|cit624","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5001\/omj.2018.92","article-title":"Delayed start protocol with gonadotropin-releasing hormone antagonist in poor responders undergoing in vitro fertilization: a randomized, double-blinded, clinical trial","volume":"33","author":"Zarei","year":"2018","journal-title":"Oman Medical Journal"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0625|cit625","unstructured":"A trial to compare highly purified human menopausal gonadotropins (hMG) and recombinant follicular stimulating hormone (rFSH) to improve pregnancy rates in infertile women https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=362154"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0626|cit626","unstructured":"Different treatment modalities for women with polycystic ovary like phenotype undergoing assisted reproduction https:\/\/dev.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=362638"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0627|cit627","unstructured":"Sequential letrozole and human menopausal gonadotropins (HMG) : the effect of a novel super ovulation protocol on pregnancy rate in polycystic ovarian syndrome patients undergoing intracytoplasmic sperm injection. Randomized controlled trial https:\/\/dev.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=365287"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0628|cit628","unstructured":"ELONVA FLARE PROTOCOL: a new approach for poor responders in superovulation for in vitro fertilisation (IVF) https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=378369"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0629|cit629","first-page":"167","article-title":"Controlled ovarian stimulation affects the immunological quality of the ovary and endometrium","volume":"69","author":"Agustina","year":"2013","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0630|cit630","first-page":"i424","article-title":"The use of human growth hormone (hGH) in poor prognosis patients increase euploidy rate and improve embryo quality. A patient controlled trial","volume":"30","author":"Aizpurua Saenz","year":"2015","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0631|cit631","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/humrep\/14.Suppl_3.209-a","article-title":"Mini-dose GnRH analogue is more efficient than co-flare protocols in the treatment of poor responders in ART cycles","volume":"14","author":"Akarsu","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0632|cit632","first-page":"i244","article-title":"Efficacy and efficiency of rFSH vs uFSH vs hMG: a randomized trial in 552 egg donors","volume":"25 Suppl 1","author":"Alam","year":"2010","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0633|cit633","first-page":"i293 Abstract n","article-title":"Type of gonadotropin does not affect either oocyte quality or follicular fluid endocrine profile during ovarian stimulation in oocyte donors","volume":"31 Suppl 1","author":"Alama Faubel","year":"2016","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0634|cit634","first-page":"1836","article-title":"Clomid plus gonadotropin versus letrozole plus gonadotropin in stimulation of infertile women","volume":"20","author":"Al-Juboory","year":"2020","journal-title":"Medico-Legal Update"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0635|cit635","first-page":"S153","article-title":"Preliminary results on economic comparison between the LHRH-antagonist cetrorelix and LHRH triptorelin to undergo controlled ovarian superovulation for assisted reproduction techniques","volume":"70","author":"Allaert","year":"1998","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0636|cit636","doi-asserted-by":"crossref","first-page":"285","DOI":"10.15296\/ijwhr.2020.46","article-title":"Agonist versus antagonist in intracytoplasmic sperm injection cycles: which is the best?","volume":"8","author":"Al-Mousawi","year":"2019","journal-title":"International Journal of Women's Health and Reproduction Sciences"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0637|cit637","first-page":"435","article-title":"A multicentre study comparing intranasal nafareline or busereline for desensitise before ovulation stimulation and IVF (poster)","volume":"21","author":"Alvarez","year":"1993","journal-title":"Contraception, Fertilit\u00e9, Sexualit\u00e9"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0638|cit638","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1016\/j.fertnstert.2014.07.759","article-title":"Comparison of antagonist to agonist in controlled ovarian stimulation (COS) cycles using human-derived gonadotropin on in vitro fertilization (IVF) outcomes. A prospective randomized controlled study","volume":"102 Suppl","author":"Anderson","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0639|cit639","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1016\/j.fertnstert.2018.07.584","article-title":"A prospective randomized trial to compare recombinant follicle stimulating hormone (rFSH) versus highly purified human menotropin (HP-hMG) for controlled ovarian stimulation on blastocyst aneuploidy rates","volume":"110","author":"Anderson","year":"2018","journal-title":"Fertility and Sterility. Conference: 74th Annual Congress of the American Society for Reproductive Medicine, ASRM 2018. Denver, Colorado, United States"},{"issue":"65","key":"10.1002\/14651858.CD012586.pub2-BIB0640|cit640","first-page":"91","article-title":"Lutropin alfa: new preparation. Combined with follitropin for follicular development: no better than menotropin","volume":"12","year":"2003","journal-title":"Prescrire International"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0641|cit641","first-page":"408","article-title":"Hyperstimulation for IVF by the 'step-down' method: preliminary results of a prospective randomized study with or without LHRH agonists.","volume":"21","author":"Antoine","year":"1993","journal-title":"Contraception, Fertilit\u00e9, Sexualit\u00e9"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0642|cit642","first-page":"141","article-title":"Clinical use of recombinant gonadotropins (FSH, LH, hCG) [French]","volume":"25","author":"Antoine","year":"1997","journal-title":"Contraception, Fertilit\u00e9, Sexualit\u00e9"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012586.pub2-BIB0643|cit643","doi-asserted-by":"crossref","first-page":"S191, Abstract","DOI":"10.1016\/S0015-0282(03)01410-9","article-title":"IVF in poor responder patients: a controlled trial between natural cycle and micro-dose GnRH analogue flare","volume":"80","author":"Aragona","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"12","key":"10.1002\/14651858.CD012586.pub2-BIB0644|cit644","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/humrep\/del207","article-title":"Cytokine and hormonal profile in blood serum and follicular fluids during ovarian stimulation with the multidose antagonist or the long agonist protocol","volume":"21","author":"Asimakopoulos","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0645|cit645","first-page":"197","article-title":"The effects of pure follicle-stimulating hormone versus human menopausal gonadotrophins on steroidogenesis and folliculogenesis during controlled ovarian hyperstimulation for in-vitro fertilization and embryo transfer","volume":"13","author":"Awwad","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0646|cit646","first-page":"249","article-title":"Gonadotrophin ovarian stimulation following pituitary desensitization and corticosteriod suppression therapy in women with idiopathic spontaneous premature ovarian failure","volume":"13","author":"Awwad","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0647|cit647","doi-asserted-by":"crossref","first-page":"S163 Abstract n","DOI":"10.1016\/j.fertnstert.2010.07.649","article-title":"Comparison of short and long GnRH agonist protocols using recombinant FSH for IVF\/ICSI: a controlled prospective study","volume":"94 Suppl 1","author":"Azem","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0648|cit648","first-page":"1","article-title":"Ovarian stimulation and embryo quality: can we perform embryo selection even before oocyte pick-up?","volume":"15","author":"Baart","year":"2012","journal-title":"Human Fertility"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0649|cit649","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.fertnstert.2004.04.066","article-title":"Effect of urinary versus recombinant follicle-stimulating hormone on platelet function and other hemostatic variables in controlled ovarian hyperstimulation","volume":"82","author":"Bar","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0650|cit650","first-page":"S109","article-title":"Comparative study of recombinant follicle stimulating hormone (recFSH) and highly purified FSH (hp FSH) plus menotrophins (hMG) in intracytoplasmic sperm injection (ICSI) program","volume":"72","author":"Batiza","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0651|cit651","doi-asserted-by":"crossref","first-page":"S150, Abstract","DOI":"10.1016\/S0015-0282(02)03784-6","article-title":"An embryonic perspective of a comparative randomized study of Lupron\/Follistim versus Follistim\/Antagon in IVF","volume":"78","author":"Batzofin","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"7-8","key":"10.1002\/14651858.CD012586.pub2-BIB0652|cit652","first-page":"697","article-title":"Purified FSH and in vitro fertilization","volume":"14","author":"Belaisch","year":"1986","journal-title":"Contraception, Fertilit\u00e9, Sexualit\u00e9"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0653|cit653","first-page":"55","article-title":"A comparative study of clomid-HMG and HMG for follicular stimulation in IVF-ER\/GIFT treatment","volume":"35","author":"Bessho","year":"1990","journal-title":"Japanese Journal of Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0654|cit654","first-page":"i63","article-title":"IVF\/ICSI cycles with the addition of rhCG microdose","volume":"20","author":"Borges Jr","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0655|cit655","first-page":"59","article-title":"Controlled ovarian hyperstimulation in women > or = 40 years old undergoing IVF-ET: mid-luteal versus early follicular (flare-up) GnRH analog regimens","volume":"26","author":"Borini","year":"1995","journal-title":"Acta Europaea Fertilitatis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0656|cit656","first-page":"P473","article-title":"Randomized comparison of 2 long and short protocols of ovarian stimulation with LHRH-agonist for IVF including 342 cycles in 175 women","volume":"6","author":"Buvat","year":"1991","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0657|cit657","first-page":"436","article-title":"Long or short GnRH-a protocol during COH for IVF","volume":"21","author":"Buvat","year":"1993","journal-title":"Contraception, Fertilit\u00e9, Sexualit\u00e9"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0658|cit658","first-page":"i103","article-title":"GnRH agonist versus GnRH antagonist in an IVF program: luteal phase hormonal characteristics","volume":"20","author":"Causio","year":"2004","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"7-8","key":"10.1002\/14651858.CD012586.pub2-BIB0659|cit659","first-page":"789","article-title":"Prospective randomized study of early addition of pure FSH in poor estradiol flare-up during short term GnRH analog protocol for IVF","volume":"20","author":"Cedrin-Durnerin","year":"1992","journal-title":"Contraception, Fertilit\u00e9, Sexualit\u00e9"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0660|cit660","first-page":"433","article-title":"Prognostic assessment of 'flare up' in response to GnRH agonist for IVF: prospective randomized trial (poster)","volume":"21","author":"Cedrin-Durnerin","year":"1993","journal-title":"Contraception, Fertilit\u00e9, Sexualit\u00e9"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD012586.pub2-BIB0661|cit661","first-page":"3S29","article-title":"Antagonist protocols: residual LH levels and the value of exogenous LH supplementation","volume":"33","author":"Cedrin-Durnerin","year":"2004","journal-title":"Journal de Gynecologie, Obstetrique et Biologie de la Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0662|cit662","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5152\/jtgga.2011.04","article-title":"Comparison of ovulation induction and pregnancy outcomes in IVF patients with normal ovarian reserve who underwent long protocol with recombinant-FSH and highly purified-hMG","volume":"12","author":"Celik","year":"2011","journal-title":"Journal of the Turkish-German Gynecological Association"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0663|cit663","first-page":"S12, Abstract n","article-title":"A comparison of pregnancy rates following in vitro fertilization in poor responders according to two different low-dose regimens of using leuprolide acetate in conjunction with gonadotropins","volume":"79","author":"Check","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0664|cit664","first-page":"12","article-title":"An evaluation of outcome following in vitro fertilization after no or minimal stimulation with gonadotropin without gonadotropin releasing hormone agonists or antagonists in previous poor responders or women with hypergonadotropism","volume":"79","author":"Check","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0665|cit665","first-page":"i122","article-title":"Evaluation of the efficacy of adding recombinant LH hormone to recombinant FSH hormone in cycles of non-selected patients submitted to controlled ovarian stimulation for assisted reproduction","volume":"20","author":"Chedid","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0666|cit666","first-page":"S25","article-title":"Ovarian responses to recombinant follicle-stimulating hormone (FSH) with and without luteinizing hormone (LH) in ovulatory women undergoing superovulation","volume":"72","author":"Cheung","year":"1999","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0667|cit667","unstructured":"Comparison the live birth rate between the early follicular phase ultra-long protocol and antagonist protocol in patients with normal ovarian response during in-vitro fertilization treatment: a single-center prospective open-label randomized controlled study https:\/\/www.chictr.org.cn\/showprojEN.html?proj=24518"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0668|cit668","unstructured":"The effectiveness and safety of the early follicular phase full-dose down-regulation protocol for controlled ovarian hyperstimulation: a randomized, paralleled controlled, multicenter trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=34886"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0669|cit669","unstructured":"Randomized controlled trial for ovarian stimulation protocol choice in TESE-ICSI of non-obstructive azoospermia https:\/\/www.chictr.org.cn\/showprojEN.html?proj=53545"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0670|cit670","unstructured":"Comparison of GnRH agonist versus GnRH antagonist protocol on the cumulative live birth rate in POSEIDON subgroup 3 patients: a randomized controlled trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=55493"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0671|cit671","unstructured":"The randomized controlled study for the effectiveness of flexible low-does cetrotide in GnRH antagonist in IVF https:\/\/www.chictr.org.cn\/showprojEN.html?proj=54316"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0672|cit672","unstructured":"A randomized controlled clinical study on the efficacy and safety of PPOS and antagonist stimulation protocol on ovarian high response infertile women undergoing IVF \/ ICSI https:\/\/www.chictr.org.cn\/showprojEN.html?proj=58627"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0673|cit673","unstructured":"Comparison of the clinical outcomes in PCOS patients using late follicular phase ovarian stimulation protocol versus GnRH antagonist protocol:a prospective, randomized, controlled trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=59842"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0674|cit674","unstructured":"The role of progesterone-primed ovarian stimulation combined with clomiphen citrate on the women with PCOS undergoing IVF treatment https:\/\/www.chictr.org.cn\/showprojEN.html?proj=13118"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0675|cit675","unstructured":"The efficacy of the ultra-long protocol and progestin-primed ovarian stimulation in infertile women with recurrent IVF failure: a randomised controlled trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=16162"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0676|cit676","unstructured":"GnRH-A and ultra short GnRH-a https:\/\/www.chictr.org.cn\/showprojEN.html?proj=20744"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0677|cit677","unstructured":"The clinical outcome of controlled ovarian stimulation using Utrogestan and HMG in women with PCOS: a prospective, randomized, controlled trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=11261"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0678|cit678","unstructured":"Comparison of the clinical outcomes for normalovulatory patients undergoing IVF procedure using mid-late follicular phase stimulation vs. luteal phase ovarian stimulation https:\/\/www.chictr.org.cn\/showprojEN.html?proj=15935"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0679|cit679","unstructured":"A prospective, interventional, randomized, controlled study to compare the clinical pregnancy rates in patients with type II Polycystic Ovary Syndrome (PCOS) receiving super-long GnRHa protocol versus long protocol with daily GnRHa in IVF https:\/\/www.chictr.org.cn\/showprojEN.html?proj=21905"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0680|cit680","unstructured":"Low dose gonadotropin with GnRH antagonist protocol compared with minimal stimulation in poor ovarian response patients https:\/\/www.chictr.org.cn\/showprojEN.html?proj=21829"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0681|cit681","unstructured":"Efficacy of highly purified HMG vs. HMG on pregnancy outcomes in vitro fertilization https:\/\/www.chictr.org.cn\/showprojEN.html?proj=10699"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0682|cit682","first-page":"716","article-title":"Efficacy of controlled ovarian hyperstimulation using GnRH antagonist in women with polycystic ovary syndrome undergoing IVF-ET","volume":"48","author":"Choi","year":"2005","journal-title":"Korean Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0683|cit683","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/j.fertnstert.2012.07.760","article-title":"IVF comparison of ART outcomes in infertile PCOS women; in vitro maturation (IVM) vs. GnRH agonist vs. GnRH antagonist cycles","volume":"98 Suppl 1","author":"Choi","year":"2012","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0684|cit684","unstructured":"A clinical trial to see the effects and safety of two drugs IVF-M\u2122 (Menotropin) and Menopur\u00ae (Menotropin) in infertile women undergoing IVF treatment Clinical Trials Registry - India"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0685|cit685","unstructured":"Phase III study to evaluate the efficacy and safety of recombinant human FSH of Cadila Healthcare Limited, India as compared to gonal-f administered subcutaneously in female patients undergoing assisted reproductive technology https:\/\/ctri.nic.in\/Clinicaltrials\/showallp.php?mid1=16431&EncHid=&userName=CTRI\/2016\/10\/007367"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0686|cit686","unstructured":"Comparative study of recombinant human menopausal gonadotrophin in treatment of infertility Clinical Trials Registry - India"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012586.pub2-BIB0687|cit687","doi-asserted-by":"crossref","first-page":"S137, Abstract","DOI":"10.1016\/S0015-0282(03)01241-X","article-title":"Quality of life (QOL) differentiation analysis in patients undergoing controlled ovarian stimulation (COS) with two different preparations of recombinant human follicle-stimulating hormone (r-hFSH)","volume":"80","author":"Daya","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012586.pub2-BIB0688|cit688","doi-asserted-by":"crossref","first-page":"S255 Abstract n","DOI":"10.1016\/S0015-0282(03)01637-6","article-title":"Oocytes and embryos assessment using GnRH agonists and antagonists","volume":"80","author":"Depalo","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0689|cit689","first-page":"i3 Abstract No:","article-title":"Outcomes in patients with poor prognosis for ovarian response to stimulation: a prospective and randomized trial","volume":"23 Suppl 1","author":"Devesa","year":"2008","journal-title":"Human Reproduction. European Society of Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0690|cit690","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humrep\/14.Suppl_3.297-a","article-title":"Basal and induced progesterone and oestradiol secretion from human granulosa-luteal cells obtained during in-vitro fertilization cycles: a comparison between the effects of ovulation induction using recombinant follicle stimulating hormone (rFSH) and pure urinary FSH","volume":"14","author":"Dirnfeld","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0691|cit691","first-page":"195, Abstract n","article-title":"The outcome of the two stimulation regimens: agonist versus antagonist","volume":"18","author":"Domitrz","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0692|cit692","first-page":"266","article-title":"Microdose GnRH agonist flare-up versus ultrashort GnRH agonist combined with fixed GnRH antagonist in poor responders of assisted reproductive techniques cycles","volume":"6","author":"Eftekhar","year":"2013","journal-title":"International Journal of Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0693|cit693","first-page":"725","article-title":"Comparison of pregnancy outcome after letrozole versus clomiphene treatment for mild ovarian stimulation protocol in poor responders","volume":"12","author":"Eftekhar","year":"2014","journal-title":"Iranian Journal of Reproductive Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0694|cit694","first-page":"671","article-title":"Progesterone-primed ovarian stimulation in polycystic ovarian syndrome: An RCT","volume":"17","author":"Eftekhar","year":"2019","journal-title":"International Journal of Reproductive Biomedicine (Yazd, Iran)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0695|cit695","first-page":"287","article-title":"Effect of adding letrozole to gonadotropin on in vitro fertilization outcomes: an RCT","volume":"18","author":"Eftekhar","year":"2020","journal-title":"International Journal of Reproductive Biomedicine"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0696|cit696","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/j.fertnstert.2016.07.565","article-title":"Low cost ovarian stimulation protocol is associated with lower pregnancy rate in normal responders in comparison to long protocol","volume":"106","author":"Elnashar","year":"2016","journal-title":"Fertility and Sterility"},{"issue":"Suppl","key":"10.1002\/14651858.CD012586.pub2-BIB0697|cit697","doi-asserted-by":"publisher","first-page":"103485","DOI":"10.1016\/j.rbmo.2023.103485","article-title":"Comparison of in vitro fertilization outcomes between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol","volume":"47","author":"Erdogan","year":"2023","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0698|cit698","unstructured":"Randomized, open-label, single centre study on ovarian stimulation in ART poor responders treated with recombinant FSH in association with recombinant LH https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2010-022032-37\/IT"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0699|cit699","unstructured":"Comparison of two different drug protocols for ovarian stimulation in women with low egg reserve undergoing first attempt of in vitro fertilization https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2012-004824-39\/GB"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0700|cit700","unstructured":"Randomized, single blind, prospective clinical study to compare hFSH-HP (Fostipur) and hMG-HP (Menopur) in patients with polycystic ovary ander a FIV\/ICSI cicle http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2014-005099-27-ES 2015"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0701|cit701","unstructured":"Randomized, single blind, prospective clinical study to compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in patients with polycystic ovary under a FIV\/ICSI cycle https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2015-005660-42"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0702|cit702","unstructured":"Effect of recombinant FSH dosing following corifollitropin alfa in patients undergoing IVF\/ICSI in a GnRH antagonist protocol: a randomized controlled dose-finding study https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2018-002000-13\/BE"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0703|cit703","first-page":"3","article-title":"Randomized prospective study on the effect of the addition of the effect of the addition of business cycles exogenous LH IVF \/ ICSI GnRH antagonist predictors in patients with low response","volume":"28","author":"Evangelio","year":"2011","journal-title":"Revista Iberoamericana de Fertilidad y Reproduccion Humana"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0704|cit704","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/humrep\/14.Suppl_3.269","article-title":"Does recombinant FSH increase embryo viability in poor responder patients?","volume":"14","author":"Ferraretti","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0705|cit705","doi-asserted-by":"crossref","first-page":"Article no. 926","DOI":"10.1155\/2014\/926172","article-title":"LH pretreatment as a novel strategy for poor responders","volume":"2014","author":"Ferraretti","year":"2014","journal-title":"BioMed Research International"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0706|cit706","doi-asserted-by":"crossref","first-page":"S28 Abstract no","DOI":"10.1016\/j.fertnstert.2010.07.106","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients at high risk of ovarian hyperstimulation syndrome: A prospective randomized controlled trial","volume":"94 Suppl 1","author":"Ferrero","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0707|cit707","first-page":"72","article-title":"Comparison of Clomid\/FSH\/HMG stimulation for IVF with and without GnRH antagonists","volume":"16","author":"Fiedler","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0708|cit708","first-page":"2659","article-title":"Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome","volume":"84","author":"Filicori","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0709|cit709","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.fertnstert.2005.02.036","article-title":"Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation","volume":"84","author":"Filicori","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0710|cit710","first-page":"181","article-title":"Role of different gonadotrophin and GnRH-agonist regimens on pituitary suppression and the outcome of controlled ovarian hyperstimulation","volume":"10","author":"Fillicori","year":"1995","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0711|cit711","doi-asserted-by":"crossref","first-page":"132, Abstract n","DOI":"10.1016\/j.fertnstert.2007.07.423","article-title":"Does leutinizing hormone activity in the form of low-dose HCG or HMG produce better outcomes for GnRH antagonist art cycles stimulated with rFSH?","volume":"88 Suppl 1","author":"Frattarelli","year":"2007","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0712|cit712","first-page":"26, Abstract no","article-title":"Luteal phase characterstics following GnRH antagonist or agonist treatment: a randomized comparative study","volume":"18","author":"Friedler","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"7-8","key":"10.1002\/14651858.CD012586.pub2-BIB0713|cit713","first-page":"670","article-title":"Randomized study of pure FSH\/HMG in ovarian stimulation with agonist (long protocol)","volume":"18","author":"Fries","year":"1990","journal-title":"Contraception, Fertilit\u00e9, Sexualit\u00e9"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0714|cit714","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.fertnstert.2012.01.007","article-title":"Sequential letrozole and HMG: a successful novel super ovulation protocol significantly improves pregnancy rate in pcos patients undergoing ICSI, randomized controlled trial","volume":"97 Suppl 1","author":"Galal","year":"2012","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0715|cit715","doi-asserted-by":"publisher","first-page":"deac105.031","DOI":"10.1093\/humrep\/deac105.031","article-title":"O-131?progesterone primed ovarian stimulation (PPOS) vs clomiphene primed ovarian stimulation (CPOS) in high responder (HR) patients undergoing controlled ovarian stimulation - a randomized control trial","volume":"37","author":"Gambhir","year":"2022","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0716|cit716","first-page":"35","article-title":"Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: a clinical endocrinological study of the ovarian response","volume":"15","author":"Geber","year":"2001","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0717|cit717","first-page":"106","article-title":"GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran","volume":"7 Suppl 1","author":"Ghahghaei","year":"2013","journal-title":"International Journal of Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0718|cit718","unstructured":"Ghosh S Chattopadhyay R Goswami S Chakravarty BN Recombinant FSH versus highly purified urinary FSH - our experience 11th World Congress on In Vitro Fertilization and Human Reproductive Genetics, 1999 May 9-14, Sydney, Australia 1999"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0719|cit719","doi-asserted-by":"crossref","first-page":"S28 Abstract no","DOI":"10.1016\/j.fertnstert.2010.07.108","article-title":"Reappraisal of IVF stimulation in good prognosis patients-aprospectiveran domized study to compare mild versus standard long protocol","volume":"94 Suppl 1","author":"Ghosh","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0720|cit720","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/09513599909167571","article-title":"Good results of milder form of ovarian stimulation in an in vitro fertilization\/intracytoplasmic sperm injection program","volume":"13","author":"Grochowski","year":"1999","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0721|cit721","first-page":"S125","article-title":"A prospective randomised study comparing GnRH-a flare up with high dose follicle stimulating hormone (FSH) versus high dose FSH stimulation alone in low responder patients in in vitro fertilization patients","volume":"58","author":"Grow","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"9563","key":"10.1002\/14651858.CD012586.pub2-BIB0722|cit722","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(07)60360-2","article-title":"A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial","volume":"369","author":"Heijnen","year":"2007","journal-title":"Lancet"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0723|cit723","doi-asserted-by":"crossref","first-page":"S51, Abstract O","DOI":"10.1016\/S0015-0282(02)03513-6","article-title":"Randomized IVF trial of recombinant FSH versus FSH\/Lh: outcomes and pain perception","volume":"Vol 78","author":"Hines","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0724|cit724","first-page":"381","article-title":"The study of follicle stimulation methods with LH-rha and hMG\/FSH in in-vitro fertilization and embryo transfer","volume":"38","author":"Hiroi","year":"1993","journal-title":"Japanese Journal of Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0725|cit725","doi-asserted-by":"crossref","first-page":"82","DOI":"10.36295\/ASRO.2019.22089","article-title":"The effectiveness of using r-HMG+r-FSH vs. r-FSH alone during COS on ICSI outcome","volume":"22","author":"Hussain","year":"2019","journal-title":"Annals of Tropical Medicine and Public Health"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0726|cit726","doi-asserted-by":"publisher","first-page":"deac104.085","DOI":"10.1093\/humrep\/deac104.085","article-title":"O-071 In progestin primed double stimulation protocol: Is luteal phase stimulation more effective than follicular phase stimulation in poor responders? A randomized controlled study","volume":"37","author":"Hussein","year":"2022","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0727|cit727","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1016\/j.fertnstert.2004.07.619","article-title":"Reproductive performance in second IVF cycles treated with the use of either GnRH anatgonists (-antag) vs GnRH agonists (-ag) after failure with long protocols with GnRH agonists: a prospective randomized trial","volume":"82","author":"Inza","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0728|cit728","unstructured":"Comparision of ART (IVF or ICSI) outcome in two different induction ovulation protocols: Gonal-F versus Fostimon, in infertile patients with PCOD https:\/\/irct.behdasht.gov.ir\/trial\/3724"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0729|cit729","unstructured":"Letrozole in assisted reproductive techniques protocol https:\/\/irct.behdasht.gov.ir\/trial\/33018"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0730|cit730","unstructured":"Choice of treatments for ovulation induction among poor responders https:\/\/irct.behdasht.gov.ir\/trial\/7098"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0731|cit731","unstructured":"Comparison of two protocols for controlled ovarian stimulation in infertile women undergoing assisted reproductive technology https:\/\/irct.behdasht.gov.ir\/trial\/6863"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0732|cit732","unstructured":"Comparison of agonist versus modified natural cycle for endometrial preparation for FET cycle in patients with severe endometriosis https:\/\/irct.behdasht.gov.ir\/trial\/32779"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0733|cit733","unstructured":"Comparison of effects of gonadotropin releasing hormon agonists and antagonists in ART cycles in infertile patients https:\/\/irct.behdasht.gov.ir\/trial\/7066"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0734|cit734","unstructured":"Comparing effect of agonist & antagonist drugs of gonadotropin releasing hormone (GnRh) in ovulation stimulation https:\/\/irct.behdasht.gov.ir\/trial\/8448"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0735|cit735","unstructured":"A phase IIIB, observational multicentre, multinational, randomized, open-label trial to compare the efficacy and safety of ovarian stimulation GONAL-f\u00ae and Luveris\u00ae starting on day 1 vs day 6 in women between 36 and 42 years of age undergoing assisted reproductive technique (ART) https:\/\/irct.behdasht.gov.ir\/trial\/9425"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0736|cit736","unstructured":"Comparing two different drug methods for infertility treatment by assisted reproduction techniques (ARTs) https:\/\/irct.behdasht.gov.ir\/trial\/10434"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0737|cit737","unstructured":"Efficacy of low-dose hCG adjunct to r-hFSH plus GnRH antagonist for ovarian stimulation in assisted reproductive technology https:\/\/irct.behdasht.gov.ir\/trial\/7604"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0738|cit738","unstructured":"Effects of GnRH antagonist versus GnRH agonist protocol on ART outcomes in poor ovarian responders https:\/\/irct.behdasht.gov.ir\/trial\/1285"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0739|cit739","unstructured":"Comparison of GnRH agonists and antagonists the outcome IVF\/ICSI in women with polycystic ovary syndrome https:\/\/irct.behdasht.gov.ir\/trial\/1294"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0740|cit740","unstructured":"Compare two different methods of ovarian stimulation on outcome of in Vvitro fertilization (IVF) https:\/\/irct.behdasht.gov.ir\/trial\/15654"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0741|cit741","unstructured":"Comparison of using of recombinant FSH long time with or without hMG in IVF\/ICSI cycles https:\/\/irct.behdasht.gov.ir\/trial\/5557"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0742|cit742","unstructured":"To assess effects of letrozole In infertility treatment https:\/\/irct.behdasht.gov.ir\/trial\/17493"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0743|cit743","unstructured":"Comparison of long protocol and agonist-antagonist protocol in the infertile normal responder patients https:\/\/irct.behdasht.gov.ir\/trial\/22056"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0744|cit744","unstructured":"Comparison of novel antagonist protocol vs agonist protocol on IVF outcome in poor response patients https:\/\/irct.behdasht.gov.ir\/trial\/19657"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0745|cit745","unstructured":"Assessment the effect of ovarian stimulation with and without letrozole in IVF\/ICSI outcomes https:\/\/irct.behdasht.gov.ir\/trial\/1544"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0746|cit746","unstructured":"Effect of medroxyprogesterone acetate in the prevention of premature LH surge in IVF cycles https:\/\/irct.behdasht.gov.ir\/trial\/46951"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0747|cit747","unstructured":"The effect of progesterone in preventing LH surge in IVF cycles https:\/\/irct.behdasht.gov.ir\/trial\/48593"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0748|cit748","unstructured":"The use of a flexible (GnRH) antagonist versus minidose long GnRH agonist for ovarian stimulation in poor-responder patients undergoing the (IVF) program www.who.int\/trialsearch\/Trial2.aspx?TrialID=ISRCTN84867406 2011"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0749|cit749","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00404-024-07387-4","article-title":"Comparison of progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in terms of preventing premature LH surge and assisted reproductive technology outcome in infertile women: a randomized controlled trial","volume":"309","author":"Jabarpour","year":"2024","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0750|cit750","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1016\/j.fertnstert.2013.07.1137","article-title":"A prospective randomised controlled study comparing a low-cost antagonist protocol using oral ovulation inducing agents in IVF-ICSI cycles with a standard agonist long protocol","volume":"100 Suppl","author":"Jindal","year":"2013","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0751|cit751","unstructured":"Comparison between clomiphene citrate plus hMG or hMG alone, combined with flexible multi dose GnRH antagonist for patients with poor prognosis in IVF-ET programs http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000008760 2012"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0752|cit752","first-page":"S111","article-title":"Randomization of IVF cycles between low dose leuprolide acetate\/hMG and clomiphene citrate\/hMG","volume":"54","author":"Jutras","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"Suppl","key":"10.1002\/14651858.CD012586.pub2-BIB0753|cit753","first-page":"i115","article-title":"Randomized comparison of GnRH antagonist and agonist regimen in 35 years of age or older undergoing ICSI","volume":"21","author":"Karabacak","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0754|cit754","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.fertnstert.2004.07.307","article-title":"A randomized prospective trial comparing alternate day GnRH agonist versus GnRH antagonist in IVF cycles","volume":"82","author":"Karatekeli","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0755|cit755","first-page":"133","article-title":"Low dose HCG Adjunct to r-hFSH\/GnRH antagonist for controlled ovarian stimulation in assisted reproductive technology: a prospective and randomized trial","volume":"6 Suppl 1","author":"Kashani","year":"2012","journal-title":"International Journal of Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0756|cit756","first-page":"49","article-title":"Randomized controlled trial of follicle-stimulating hormone versus human menopausal gonadotropin in controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer","volume":"40","author":"Jee","year":"1997","journal-title":"Korean Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0757|cit757","unstructured":"Kingsland C Owen E Davies M Mason B Prospective randomised trial comparing ovarian stimulation regimens for in-vitro fertilisation and embryo transfer Silver Jubilee British Congress of Obstetrics and Gynaecology; 1989 July 4-7, London, England London, England 1989"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0758|cit758","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1016\/j.fertnstert.2005.07.780","article-title":"A prospective randomized study of three different controlled ovarian hyperstimulation (COH) protocols","volume":"84","author":"Kyono","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0759|cit759","first-page":"70","article-title":"Will letrozole improve the ovarian response and live-birth rate in women with poor ovarian reserve who are undergoing in-vitro fertilisation treatment? A randomised controlled trial","volume":"14 Suppl 2","author":"Lee","year":"2011","journal-title":"Human Fertility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0760|cit760","first-page":"S15","article-title":"The efficacy of natural versus stimulated cycle IVF-ET","volume":"56","author":"Levy","year":"1991","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0761|cit761","first-page":"134","article-title":"Better implantation rate overimposing recombinant LH (Luveris) on recombinant FSH (Gonal F) in multiple follicular stimulation for IVF","volume":"17","author":"Lisi","year":"2002","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0762|cit762","first-page":"114, Abstract n","article-title":"GnRh antagonist versus GnRh agonist in good prognosis IVF patients","volume":"18","author":"Londra","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0763|cit763","first-page":"519","article-title":"GnRH-a + hMG (short protocol) vs cc + hMG during COH for IVF","volume":"16","author":"Lopes","year":"1987","journal-title":"Journal de Gynecologie, Obstetrique et Biologie de la Reproduction"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0764|cit764","doi-asserted-by":"publisher","first-page":"deac107.585","DOI":"10.1093\/humrep\/deac107.585","article-title":"P-636 Use of Desogestrel as an alternative to GnRH antagonists to inhibit the LH surge: a prospective randomized controlled observational study","volume":"37","author":"Lorenzo","year":"2022","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0765|cit765","first-page":"30","article-title":"Does the addition of menopausal gonadotropin to recombinant FSH in pituitary suppressed women improve clinical pregnancy in an intracytoplasmic sperm injection program?","volume":"8","author":"Loutradis","year":"2003","journal-title":"Middle East Fertility Society Journal"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0766|cit766","first-page":"3, Abstract no:","article-title":"LH Supplementation in GnRH antagonist protocols: preliminary results of a prospective, randomized study","volume":"18","author":"Ludwig","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0767|cit767","first-page":"37, Abstract FC","article-title":"Highly purified gonadotropin and recombinant gonadotropin: study in IVF cycles","volume":"13, Suppl 3","author":"Machado","year":"1999","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0768|cit768","first-page":"81","article-title":"Compare the effcacy of two protocols of ovarian stimulation using re-combinant FSH plus recombinant LH versus recombinant LH alone in hypog-onadotropic hypogonadal women undergoing in vitro fertilization\/intracytoplas-mic sperm injection (IVF\/ICSI)","volume":"9","author":"Madani","year":"2015","journal-title":"International Journal of Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0769|cit769","first-page":"92","article-title":"Controlled ovarian stimulation (COS) in assisted reproductive technologies: rFSH alone or RFSH and HMG combined?","volume":"16","author":"Mahmoud","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0770|cit770","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.fertnstert.2013.07.1695","article-title":"Microdose GnRH agonist flare-up versus flexible GnRH antagonist protocol in poor responders undergoing in-vitro-fertilization (IVF) cycles: a randomized controlled trial","volume":"100 Suppl","author":"Malhotra","year":"2013","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0771|cit771","first-page":"4","article-title":"GnRH antagonist\/Letrozole in poor responderes for ICSI; versus microdose flare up GnRH agonist","volume":"11","author":"Mansouri","year":"2013","journal-title":"Iranian Journal of Reproductive Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012586.pub2-BIB0772|cit772","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1016\/j.fertnstert.2004.07.627","article-title":"Comparison of IVF outcome with GnRH agonist and antagonist protocols in normal responders. A prospective randomized trial","volume":"82","author":"Marrs","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0773|cit773","article-title":"Randomised prospective study of the effect of adding exogenous LH activity on IVF \/ ICSI cycles with GnRH antagonists in patients with low-response predictive factors","volume":"28","author":"Matallin","year":"2011","journal-title":"Revista Iberoamericana de Fertilidad y Reproducci\u00f3n Humana"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0774|cit774","first-page":"371","article-title":"Comparison between FSH-HP and hMG in IVF","volume":"25","author":"Mayenga","year":"1997","journal-title":"Contraception Fertilit\u00e9 Sexualit\u00e9"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0775|cit775","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1016\/j.fertnstert.2009.07.1258","article-title":"Menopur versus rFSH in GnRH antagonist cycles","volume":"92 Suppl 1","author":"Miller","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0776|cit776","first-page":"i121 Abstract N","article-title":"GnRH antagonist versus long GnRH agonists protocol in PCOS patients undergoing IVF treatment","volume":"22 Suppl 1","author":"Moshin","year":"2007","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0777|cit777","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/j.fertnstert.2011.07.682","article-title":"Randomised study of clinical pregnancy rates using different gonadotropins in IVF\/ICSI cycles","volume":"96","author":"Motan","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0778|cit778","first-page":"i122","article-title":"Supplementation with rec-FSH or rec-LH is equally effective to modulate suboptimal response for IVF cycles. A prospective, randomized trial","volume":"20","author":"Motta","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0779|cit779","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1016\/j.fertnstert.2022.09.088","article-title":"Progesterone primed ovarian stimulation protocol (PPOS) vs gnrh antagonist for patients of freeze all cycles: a prospective randomised controlled trial","volume":"118","author":"Nayar Kanad","year":"2022","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0780|cit780","doi-asserted-by":"crossref","first-page":"i311","DOI":"10.1093\/humrep\/det221","article-title":"rLH supplementation to rFSH during induced ovarian stimulation in the GnRH antagonist protocol improves implantation and pregnancy rates","volume":"28 Suppl 1","author":"Nazzaro","year":"2013","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0781|cit781","unstructured":"Efficacy and tolerability of human FSH versus recombinant FSH (follitropin alpha) in ICSI https:\/\/clinicaltrials.gov\/show\/NCT00335725"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0782|cit782","unstructured":"Clinical efficacy and tolerability of two FSH preparations (human FSH versus rFSH - follitropin alpha) in women undergoing IVF https:\/\/clinicaltrials.gov\/show\/NCT00378001"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0783|cit783","unstructured":"Comparison of the long GnRH agonist protocol and the flexible GnRH antagonist protocol of ovarian stimulation https:\/\/clinicaltrials.gov\/show\/NCT00417183"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0784|cit784","unstructured":"Pregnancy outcomes with a GnRH antagonist protocol versus GnRH-agonist protocol in ICSI cycles https:\/\/clinicaltrials.gov\/show\/NCT00485537"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0785|cit785","unstructured":"A Comparison of the microdose leuprolide protocol vs. luteal phase ganirelix protocol in women who are or who are predicted to be low responders https:\/\/clinicaltrials.gov\/show\/NCT00633555"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0786|cit786","unstructured":"Efficacy of urinary follicle-stimulating hormone (FSH) among poor responders https:\/\/clinicaltrials.gov\/show\/NCT00677573"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0787|cit787","unstructured":"MENOPUR\u00ae versus FOLLISTIM\u00ae https:\/\/clinicaltrials.gov\/show\/NCT00802360"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0788|cit788","unstructured":"Menopur\u00ae versus Follistim\u00ae in polycystic ovarian syndrome (PCOS) https:\/\/clinicaltrials.gov\/show\/NCT00805935"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0789|cit789","unstructured":"Antagonist\/letrozole in poor responders https:\/\/clinicaltrials.gov\/show\/NCT00823004"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0790|cit790","unstructured":"Agonist gonadotropin-releasing hormone (GnRH) versus antagonist GnRH https:\/\/clinicaltrials.gov\/show\/NCT00823602"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0791|cit791","unstructured":"Clomiphene citrate (CC)\/gonadotropin\/gonadotropin releasing hormone (GnRH) antagonist versus gonadotropin\/GnRH agonist https:\/\/clinicaltrials.gov\/show\/NCT00830492"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0792|cit792","unstructured":"Polycystic ovary syndrome (PCOS) and in vitro fertilization (IVF): a comparison between standard long protocol versus an antagonist protocol starting on day 1 https:\/\/clinicaltrials.gov\/show\/NCT00883766"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0793|cit793","unstructured":"Letrozole combined with gonadotropins (Gn) for ovarian stimulation undergoing in vitro fertilization\/intracytoplasmic sperm injection (IVF\/ICSI) in patients with polycystic ovary syndrome (PCOS) https:\/\/clinicaltrials.gov\/show\/NCT00894608"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0794|cit794","unstructured":"The effect of luteinizing hormone (LH) supplementation following gonadotropin-releasing hormone (GnrRH) antagonist administration in advanced reproductive ageing women undergoing IVF and embryo transfer (IVF\/ET) https:\/\/clinicaltrials.gov\/show\/NCT01016210"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0795|cit795","unstructured":"Study to evaluate if the addition of r-hLH (Luveris\u00ae) to FSH from day 8 of ovarian stimulation is able to decrease total FSH dose and to improve cycle outcome in infertile women undergoing ART, who required high FSH dose in a previous cycle https:\/\/clinicaltrials.gov\/show\/NCT01071200"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0796|cit796","unstructured":"A phase II study to assess the efficacy and safety of Luveris\u00ae (lutropin alfa) in mid follicular phase for controlled ovarian stimulation (COS) in advanced reproductive age https:\/\/clinicaltrials.gov\/show\/NCT01079949"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0797|cit797","unstructured":"A randomised, phase II, comparative study with a parallel control for evaluating the efficacy and safety of combined treatment of lutropin alpha and recombinant human luteinizing hormone in the middle of the controlled ovarian stimulation follicular phase in women with reduced ovarian reserve https:\/\/clinicaltrials.gov\/show\/NCT01110707"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0798|cit798","unstructured":"Mild stimulation protocol versus microdose gonadotropin-releasing hormone agonist flare up protocol in poor responders https:\/\/clinicaltrials.gov\/show\/NCT01213147"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0799|cit799","unstructured":"Recombinant versus highly purified FSH in polycystic ovary syndrome (PCOS) https:\/\/clinicaltrials.gov\/show\/NCT01337531"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0800|cit800","unstructured":"In vitro fertilization outcomes of two treatment protocols in women with polycystic ovary syndrome https:\/\/clinicaltrials.gov\/show\/NCT01354275"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0801|cit801","unstructured":"GnRH antagonist versus GnRH agonist in polycystic ovary syndrome during in vitro fertilization - embryo transfer https:\/\/clinicaltrials.gov\/show\/NCT01402336"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0802|cit802","unstructured":"Comparing ovarian stimulation for assisted reproduction with two different forms of pituitary suppression https:\/\/clinicaltrials.gov\/show\/NCT01565265"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0803|cit803","unstructured":"RCT of low-dose clomiphene vs. high dose gonadotropin protocol for IVF poor responders https:\/\/clinicaltrials.gov\/show\/NCT01577199"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0804|cit804","unstructured":"Effect of GnRH antagonist vs agonist long on IVF outcome, peak estradiol level, and duration of stimulation https:\/\/clinicaltrials.gov\/show\/NCT01669291"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0805|cit805","unstructured":"Evaluation of efficacy and safety of highly purified urofollitropin in Chinese females undergoing an assisted reproductive technology (ART) program https:\/\/clinicaltrials.gov\/show\/NCT01922193"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0806|cit806","unstructured":"Comparison of ovarian mild stimulation and controlled ovarian stimulation in poor ovarian responders https:\/\/clinicaltrials.gov\/show\/NCT01926210"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0807|cit807","unstructured":"The comparison of effect of four different treatment protocols on IVF outcomes in poor responders undergoing in vitro fertilization https:\/\/clinicaltrials.gov\/show\/NCT01948804"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0808|cit808","unstructured":"FSH in GnRH-antagonist controlled ovarian hyperstimulation cycles (FAST) https:\/\/clinicaltrials.gov\/show\/NCT01969201"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0809|cit809","unstructured":"Long acting FSH plus antagonist versus daily FSH plus antagonist versus short agonist protocol in poor responders undergoing IVF https:\/\/clinicaltrials.gov\/show\/NCT02070198 2014"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0810|cit810","unstructured":"Effect of treatment with corifollitropin alpha in vitro fertilization in patients with poor ovarian response https:\/\/clinicaltrials.gov\/show\/NCT02118051"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0811|cit811","unstructured":"Comparison of 2 ovarian stimulation protocols for women with low ovarian reserve https:\/\/clinicaltrials.gov\/show\/NCT02128360"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0812|cit812","unstructured":"Ultrashort GnRH agonist\/antagonist versus GnRH antagonist IVF https:\/\/clinicaltrials.gov\/show\/NCT02173977"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0813|cit813","unstructured":"Clomiphene citrate in combination with gonadotropins for ovarian stimulation in women with poor ovarian response https:\/\/clinicaltrials.gov\/show\/NCT02237755"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0814|cit814","unstructured":"Corifollitropin alfa versus daily rFSH in the controlled ovarian stimulation of poor responders https:\/\/clinicaltrials.gov\/show\/NCT02254928"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0815|cit815","unstructured":"Comparative study between minidose long protocol and microdose flare protocol in controlled ovarian hyperstimulation https:\/\/clinicaltrials.gov\/show\/NCT02342197"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0816|cit816","unstructured":"Mono-menotropins versus rFSH protocol on embryo quality https:\/\/clinicaltrials.gov\/show\/NCT02418533"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0817|cit817","unstructured":"Letrozole in assisted reproductive technology https:\/\/clinicaltrials.gov\/show\/NCT02429999"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0818|cit818","unstructured":"Role of aromatase inhibitor to enhance ovulation in poor responder during induction with short antagonist protocol in cases of ICSI https:\/\/clinicaltrials.gov\/show\/NCT02741154"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0819|cit819","unstructured":"Study to compare hFSH-HP (Fostipur) and hMG-HP (Meriofert) in patients with polycystic ovary under a IVF\/ICSI cycle https:\/\/clinicaltrials.gov\/show\/NCT02785822"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0820|cit820","unstructured":"Low dose GnRHa early luteal phase down regulation versus GnRHa ultra-short protocol for poor ovarian response https:\/\/clinicaltrials.gov\/show\/NCT02940535"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0821|cit821","unstructured":"Corifollitropin alfa combined with menotropin versus follitropin and lutropin alfa in expected suboptimal responders https:\/\/clinicaltrials.gov\/show\/NCT03177538"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0822|cit822","unstructured":"Elonva in combination with Hp-FSH versus elonva with low dose hCG https:\/\/clinicaltrials.gov\/show\/NCT03208972"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0823|cit823","unstructured":"Different protocols in ovarian stimulation in intracytoplasmic sperm injection cycles https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04193930"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0824|cit824","unstructured":"Mild ovarian stimulation in women with poor ovarian response undergoing IVF and ICSI https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=NL-OMON26313"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0825|cit825","first-page":"S50","article-title":"A randomised comparative multicentre clinical trial of recombinant and urinary human FSH in in vitro fertilisation and embryo transfer (IV-FET)","volume":"60","author":"O'Dea","year":"1993","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0826|cit826","first-page":"ii302","article-title":"A randomized prospective study of a gonadotropin- releasing hormone antagonist versus agonist microdose flare-up protocol in poor responder patients","volume":"27 Suppl 2","author":"Ozdogan","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0827|cit827","unstructured":"Antagonist versus agonist protocols: in patients with polycystic ovary syndrome treated for ICSI cycles https:\/\/pactr.samrc.ac.za\/TrialDisplay.aspx?TrialID=933"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0828|cit828","unstructured":"Gonadotropin releasing hormone agonist flare-up versus gonatotropin releasing hormone antagonist protocols in poor responders undergoing ICSI:RCT https:\/\/pactr.samrc.ac.za\/TrialDisplay.aspx?TrialID=2212"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0829|cit829","doi-asserted-by":"publisher","first-page":"dead093.997","DOI":"10.1093\/humrep\/dead093.997","article-title":"P-671 Comparing clomiphene citrate\/ flexible GnRH antagonist vs ultrashort flare GnRH agonist protocols for controlled ovarian stimulation in poor ovarian reserve patients","volume":"38","author":"Parhar","year":"2023","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0830|cit830","first-page":"235","article-title":"Human menopausal gonadotropins in combination for stimulation does not improve IVF outcomes in POSEIDON group 4 patients, when compared to recombinant follicle stimulating hormone alone: a prospective randomized, non-blinded, controlled pilot trial","volume":"50","author":"Qiu","year":"2023","journal-title":"CEOG"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0831|cit831","article-title":"The use of GnRH antagonists since the start of stimulation in PCOS patients, reduces the risk of ovarian hyperstimulation","volume":"29","author":"Rag","year":"2012","journal-title":"Revista Iberoamericana de Fertilidad y Reproduccion Humana"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0832|cit832","unstructured":"Easier and less expensive ovarian stimulation for women at high risk for ovarian hyperstimulation: a randomized controlled trial www.who.int\/trialsearch\/Trial2.aspx?TrialID=RBR-736jwh 2019"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0833|cit833","first-page":"S131","article-title":"Recombinant human follicle-stimulating hormone (R-hFSH: gonal-F) versus highly purified urinary hFSH (u-hFSH-HP; metrodin HP) for the induction of superovulation in women undergoing assisted reproductive techniques","volume":"70","author":"Righini","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0834|cit834","first-page":"i317","article-title":"New protocol of ovulation induction with GnRH antagonist compared with GnRH analogue long protocol in IVFET\/ICSI cycles","volume":"25 Suppl 1","author":"Saini","year":"2010","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0835|cit835","first-page":"i216","article-title":"Early recombinant-LH supplementation improves oocyte competence acting on oxidative stress in young poor responder IVF-patients","volume":"35 (Suppl 1)","author":"Santonastaso","year":"2020","journal-title":"Human Reproduction. Conference: 36th Annual Meeting of the European Human Reproduction and Embryology. ESHRE. Virtual Meeting 2020"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0836|cit836","first-page":"i295 Abstract n","article-title":"Contraceptive pill and gonadotropin-releasing hormone (GnRH) flare-up agonist versus GnRH antagonist protocol in poor responders: lessons to a prospective study","volume":"30 Suppl 1","author":"Scheffler","year":"2015","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0837|cit837","first-page":"i53 Abstract no","article-title":"Amazing low cost IVF\/ICSI induction protocol in developing countries","volume":"29 Suppl 1","author":"Shah","year":"2014","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0838|cit838","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/humrep\/14.9.2230","article-title":"A prospective randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization","volume":"14","author":"Sills","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0839|cit839","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/humrep\/14.Suppl_3.296-a","article-title":"An open, randomized, group-comparative study to investigate the efficacy of uregon versus Metrodin in a fixed dose protocol in fertile subjects undergoing in-vitro fertilization","volume":"14","author":"Soong","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0840|cit840","first-page":"75","article-title":"Long GnRH agonist vs. GnRH antagonist protocol in randomized controlled trial in unselected patients--hormonal and cycle characteristics--pilot study. [Czech]","volume":"74","author":"Streda","year":"2009","journal-title":"Ceska Gynekologie"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0841|cit841","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1016\/j.fertnstert.2009.07.1585","article-title":"Selection of an optimal controlled ovarian hyperstimulation method in relation to the number of antral follicles in patients less than 40 years old","volume":"92 Suppl 1","author":"Tanaka","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0842|cit842","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/j.fertnstert.2014.07.088","article-title":"Comparative analysis of the clinical results of mild stimulation cycles and controlled stimulation cycles for art patients less than 40 years old","volume":"102 Suppl","author":"Tanaka","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0843|cit843","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5935\/1518-0557.20220006","article-title":"Medroxyprogesterone acetate versus gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surge in hyper-responder women undergoing controlled ovarian stimulation for IVF\/ICSI cycles","volume":"27","author":"Tandulwadkar","year":"2023","journal-title":"JBRA Assisted Reproduction"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0844|cit844","first-page":"25","article-title":"Is long-protocol gonadotropin releasing hormone agonist administration superior to the short protocol in ovarian stimulation for in vitro fertilization?","volume":"40","author":"Tasdemir","year":"1995","journal-title":"International Journal of Fertility and Menopausal Studies"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0845|cit845","first-page":"S12","article-title":"A multi-center, randomized, comparative, open-label trial to assess the safety and efficacy of gonal-F (r-HFSH) versus gonal-F and recombinant human luteinizing hormone (r-HLH) in patients undergoing ICSI: preliminary data","volume":"72","author":"Werlin","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0846|cit846","first-page":"S82","article-title":"Recombinant hCG: results from a randomised multicenter US trial in ART","volume":"70","author":"Chang","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0847|cit847","first-page":"187","article-title":"Influence of exogenous supplementation with luteinizing hormone during controlled ovarian hyperstimulation on the results of IVF cycle","volume":"70","author":"Toporcerov\u00e1","year":"2005","journal-title":"Ceska Gynekologie"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0848|cit848","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/01443615.2021.1873921","article-title":"Does LH supplementation in poor responders affect granulosa cells apoptosis rate in ART? A prospective randomised controlled trial","volume":"42","author":"Tosun","year":"2022","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0849|cit849","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.fertnstert.2009.07.1042","article-title":"Influence of ovarian stimulation with HMG or recombinant FSH on OHSS prevention in PCO patients undergoing IVF","volume":"92 Suppl 1","author":"Turkcapar","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0850|cit850","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF01130591","article-title":"Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study","volume":"7","author":"de-Helder","year":"1990","journal-title":"Journal of in Vitro Fertilization and Embryo Transfer"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0851|cit851","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/humrep\/14.Suppl_3.193","article-title":"Open, multicentre, prospective, randomized study comparing r-hFSH therapy alone versus combination therapy (r-hFSH + r-hLH) in patients pituitary-desensitized with low dose luteal GnRH agonist protocol: preliminary results","volume":"14","author":"Weathersbee","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"7","key":"10.1002\/14651858.CD012586.pub2-BIB0852|cit852","first-page":"44","article-title":"Effects of two different controlled ovarian stimulated protocols on outcome of aged infertility woman more than 35 years old undergoing IVF-ET","volume":"26","author":"Yanping","year":"2012","journal-title":"Chinese Journal of Andrology"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0853|cit853","doi-asserted-by":"publisher","first-page":"2316005","DOI":"10.1080\/14647273.2024.2316005","article-title":"Cumulative live birth rate of in vitro fertilization cycle via progestin-primed ovarian stimulation versus gonadotropin-releasing hormone antagonist protocol in infertile women with normal ovarian reserve: an open-label, randomized controlled trial","volume":"27","author":"Ye","year":"2024","journal-title":"Human Fertility"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0854|cit854","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S1472-6483(10)62471-6","article-title":"Clomiphene citrate for poor responder women undergoing IVF\/ICSI treatment cycles: randomised controlled study","volume":"20 Suppl 3 Abst","author":"Youssef","year":"2010","journal-title":"Reproductive Biomedicine Online"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0855|cit855","first-page":"58 Abstract no:","article-title":"Comparison of GnRH agonists and antagonists in the outcome of IVF\/ICSI in women with polycystic ovary syndrome","volume":"12","author":"Zeinalzadeh","year":"2014","journal-title":"Iranian Journal of Reproductive Medicine"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012586.pub2-BIB0856|cit856","first-page":"58","article-title":"Comparison of GnRH antagonist versus GnRH agonist on ART outcomes in patients with poor ovarian response","volume":"12","author":"Zeinalzadeh","year":"2014","journal-title":"Iranian Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0857|cit857","unstructured":"Application of ovarian stimulation based on the age in patients with poor ovarian response https:\/\/www.chictr.org.cn\/showprojEN.html?proj=27497"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0858|cit858","unstructured":"LH based flexible GnRH antagonist protocol in women with normal ovarian response undergoing in vitro fertilization and embryo transfer:a randomized controlled trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=27389"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0859|cit859","unstructured":"LH based flexible GnRH antagonist protocol in PCOS patient undergoing in vitro fertilization and embryo transfer: a randomized controlled trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=27624"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0860|cit860","unstructured":"GnRH antagonist and progestin used for preventing premature ovulation in infertile women during IVF\/ICSI treatment: a prospective randomized controlled trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=30508"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0861|cit861","unstructured":"Clinical comparison of long acting agonist protocol and short acting agonist protocol of in vitro fertilization and embryo transfer: a randomized controlled trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=35835"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0862|cit862","unstructured":"The effect of modified progestin primed ovarian stimulation program in whole embryo freezing cycle in the treatment of infertile patients: a randomized controlled trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=50033"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0863|cit863","unstructured":"Efficacy and safety of letrozole combined with gonadotropin in ovulation induction in elderly patients with poor ovarian reserve: a multicenter, prospective, non-blind, randomized controlled clinical trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=66300"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0864|cit864","unstructured":"The effect of recombinant luteinizing hormone (LH) supplementation in controlled ovarian hyperstimulation outcome in women with low LH concentration during mid- and late-follicular phase: a single-center, prospective, randomized controlled study https:\/\/www.chictr.org.cn\/showprojEN.html?proj=122132"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0865|cit865","unstructured":"Comparison of endometrial receptivity between GnRH-antagonist protocol and GnRH-agonist protocol in normal ovarian responders: a randomized controlled trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=122495"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0866|cit866","unstructured":"Comparison of the clinical outcomes for normalovulatory patients undergoing IVF procedure using mid-late follicular phase stimulation vs. Utrogestan protocol https:\/\/www.chictr.org.cn\/showprojEN.html?proj=15936"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0867|cit867","unstructured":"A comparison of outcomes from ART cycles stimulated with recombinant follicle stimulating hormone and highly purified human menopausal gonadotropin https:\/\/www.chictr.org.cn\/showprojEN.html?proj=10081"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0868|cit868","unstructured":"The clinical outcome of two ovarian stimulation protocols without prolonged pituitary down-regulation for endometriosis patients undergoing IVF\/ICSI cycles https:\/\/www.chictr.org.cn\/showprojEN.html?proj=10721"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0869|cit869","unstructured":"Comparison of different gonadotropins in PCOS patients undergoing in vitro fertilization: a randomized controlled trial https:\/\/www.chictr.org.cn\/showprojEN.html?proj=14127"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0870|cit870","unstructured":"The effect of clomiphene citrate on clinical outcome in progestin-primed ovarian stimulation in women with polycystic ovarian syndrome undergoing IVF cycle https:\/\/www.chictr.org.cn\/showprojEN.html?proj=22050"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0871|cit871","unstructured":"The clinical outcomes of MPA and duphaston and utrogestan in primed-progesterone ovarian stimulation protocol for patients with polycystic ovarian syndrome undergoing IVF cycle https:\/\/www.chictr.org.cn\/showprojEN.html?proj=22049"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0872|cit872","unstructured":"A prospective, randomized, controlled tial of recombinant FSH combined with HP-HMG on ovarian response and clinical outcomes https:\/\/www.chictr.org.cn\/showprojEN.html?proj=4609"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0873|cit873","unstructured":"Prospective, randomized open trial to evaluate the efficacy of highly purified urinary FSH (Fostipur\u00ae, IBSA) versus recombinant FSH (Bemfola\u00ae Finox) in oocyte donors undergoing controlled ovarian stimulation based on receptor N680S FSH gene polymorphism https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2015-003779-31"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0874|cit874","unstructured":"A trial to compare the efficacy and safety of individualised FE 999049 (follitropin delta) dosing in women undergoing controlled ovarian stimulation https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2017-002783-40"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0875|cit875","unstructured":"Comparison of two ovarian stimulation protocols in polycystic ovarian syndrome (PCOS) patients undergoing IVF\/ICSI https:\/\/irct.behdasht.gov.ir\/trial\/53232"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0876|cit876","unstructured":"Comparison the effect of combining letrozole and gonadotropin with gonadotropin alone on the IVF \/ ICSI cycle success rate in women with endometriosis https:\/\/irct.behdasht.gov.ir\/trial\/54384"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0877|cit877","unstructured":"Flexible progestin primed ovarian stimulation in patients with polycystic ovarian syndrome https:\/\/irct.behdasht.gov.ir\/trial\/55245"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0878|cit878","unstructured":"Comparison of luteal phase stimulation with follicular phase stimulation in poor ovarian response https:\/\/irct.behdasht.gov.ir\/trial\/55402"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0879|cit879","unstructured":"Letrozole in stimulated IVF cycles https:\/\/clinicaltrials.gov\/show\/NCT02912988"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0880|cit880","unstructured":"Follitropin delta in long GnRH agonist and GnRH antagonist protocols (BEYOND) https:\/\/clinicaltrials.gov\/show\/NCT03809429"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0881|cit881","unstructured":"Extended letrozole regimen co-treatment with gonadotropin releasing hormone antagonist protocol versus gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET. A randomized controlled trial https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04268927"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0882|cit882","unstructured":"Protocols of IVF\/ICSI in poor responders clinicaltrials.gov\/show\/NCT04356105"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0883|cit883","unstructured":"Comparison of the euploid rate of blastocyst between PPOS and GnRH antagonist protocol in patients undergoing PGT-A https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04414748"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0884|cit884","unstructured":"Live birth rate between PPOS and GnRH antagonist protocol in patients with anticipated high ovarian response https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04414761"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0885|cit885","unstructured":"A randomized comparison of one controlled ovarian stimulation with corifollitropin alfa versus up to three modified natural cycles in expected and established poor responders https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04487925"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0886|cit886","unstructured":"Progestin primed double stimulation protocol versus flexible GnRH antagonist protocol in poor responders https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04537078"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0887|cit887","unstructured":"Effect of controlled ovarian stimulation in quality of eocyte and embryo https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04539067"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0888|cit888","unstructured":"The rate of embryo euploidy in progestin-primed ovarian stimulation cycles https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04654741"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0889|cit889","unstructured":"PErsonalized addition of recombinant LH in ovarian stimulation https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04719000"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0890|cit890","unstructured":"Desogestrel versus GnRH antagonist in IVF\/ICSI https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04728659"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0891|cit891","unstructured":"Intensity of ovarian stimulation and embryo quality https:\/\/clinicaltrials.gov\/show\/NCT04983173"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0892|cit892","unstructured":"Euploid rate of blastocyst derived from PPOS vs antagonist protocol https:\/\/clinicaltrials.gov\/show\/NCT04989348"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0893|cit893","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/s1472-6483(10)61661-6","article-title":"Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol","volume":"10","author":"Aboulghar Mohamed","year":"2005","journal-title":"Reproductive Biomedicine Online"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0894|cit894","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010550.pub2","article-title":"Natural cycle in vitro fertilisation (IVF) for subfertile couples","author":"Allersma","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0895|cit895","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001750.pub3","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0896|cit896","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata","year":"2021","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0897|cit897","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0898|cit898","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/1536867X1501500402","article-title":"Visualizing assumptions and results in network meta-analysis: the network graphs package","volume":"15","author":"Chaimani","year":"2015","journal-title":"Stata Journal"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0899|cit899","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7827-10-26","article-title":"GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF\/ET)","volume":"10","author":"Depalo","year":"2012","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0900|cit900","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0901|cit901","doi-asserted-by":"publisher","first-page":"102301","DOI":"10.1016\/j.bpobgyn.2022.102301","article-title":"Treatment algorithms for high responders: what we can learn from randomized controlled trials, real-world data and models","volume":"86","author":"Drakopoulos","year":"2023","journal-title":"Best Practice & Research Clinical Obstetrics & Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0902|cit902","doi-asserted-by":"crossref","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI","volume":"2020","author":"Bosch","year":"2020","journal-title":"Human Reproduction Open"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0903|cit903","unstructured":"GRADEpro GDT McMaster University and Evidence Prime 2022"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0904|cit904","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins JP","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0905|cit905","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/training.cochrane.org\/handbook"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0906|cit906","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/humrep\/dem270","article-title":"Are GnRH antagonists comparable to agonists for use in IVF?","volume":"22","author":"Huirne","year":"2007","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0907|cit907","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1503\/cmaj.081086","article-title":"Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses","volume":"181","author":"Ioannidis","year":"2009","journal-title":"Canadian Medical Association Journal"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0908|cit908","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008528.pub3","article-title":"Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation","author":"Kamath","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012586.pub2-BIB0909|cit909","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Human Reproduction Update"},{"issue":"1","key":"10.1002\/14651858.CD012586.pub2-BIB0910|cit910","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12905-022-01964-y","article-title":"Predicting IVF outcome in poor ovarian responders","volume":"22","author":"Lebovitz","year":"2022","journal-title":"BMC Women's Health"},{"issue":"6","key":"10.1002\/14651858.CD012586.pub2-BIB0911|cit911","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009517.pub4","article-title":"Endometrial injury in women undergoing in vitro fertilisation (IVF)","author":"Lensen","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0912|cit912","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005070.pub2","article-title":"Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles","author":"Mochtar","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0913|cit913","doi-asserted-by":"publisher","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0914|cit914","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2025"},{"issue":"11","key":"10.1002\/14651858.CD012586.pub2-BIB0915|cit915","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006919.pub4","article-title":"Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction","author":"Siristatidis","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0916|cit916","unstructured":"Stata Statistical Software: Release 17 StataCorp LP 2021"},{"key":"10.1002\/14651858.CD012586.pub2-BIB0917|cit917","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"9","key":"10.1002\/14651858.CD012586.pub2-BIB0918|cit918","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD012586.pub2-BIB0919|cit919","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005354.pub2","article-title":"Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles","author":"Van Wely","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012586.pub2-BIB0920|cit920","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/humrep\/deaa126","article-title":"Network meta-analyses in reproductive medicine: challenges and opportunities","volume":"35","author":"Wang","year":"2020","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD012586.pub2-BIB0921|cit921","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/1536867X1501500403","article-title":"Network meta-analysis","volume":"15","author":"White","year":"2015","journal-title":"Stata Journal"},{"issue":"3","key":"10.1002\/14651858.CD012586.pub2-BIB0922|cit922","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012586","article-title":"Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis","author":"Gallos","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:14:38Z","timestamp":1770394478000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012586.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":922,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012586.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}